,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,321380,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,9606.0,Homo sapiens (human),[benzo(a)pyrene binds to AHR protein] which results in increased expression of UGT1A6,,,PMID:23656968,https://www.ncbi.nlm.nih.gov/pubmed/23656968,23656968,,
1,321381,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,94284,UGT1A6A,https://ctdbase.org/detail.go?type=gene&acc=94284,,,94284.0,Ugt1a6a,10090.0,Mus musculus (house mouse),AHR protein promotes the reaction [benzo(a)pyrene results in increased expression of UGT1A6A mrna],,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
2,321382,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,94284,UGT1A6A,https://ctdbase.org/detail.go?type=gene&acc=94284,,,94284.0,Ugt1a6a,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of UGT1A6A mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
3,321383,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,94284,UGT1A6A,https://ctdbase.org/detail.go?type=gene&acc=94284,,,94284.0,Ugt1a6a,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of UGT1A6A mRNA,,,PMID:15034205|PMID:19770486|PMID:20127859|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/15034205|https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/20127859|https://www.ncbi.nlm.nih.gov/pubmed/32417428,15034205|19770486|20127859|32417428,,
4,322353,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,243085,UGT2B35,https://ctdbase.org/detail.go?type=gene&acc=243085,,,243085.0,Ugt2b35,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of UGT2B35 mRNA,,,PMID:19770486|PMID:20127859|PMID:21715664|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/20127859|https://www.ncbi.nlm.nih.gov/pubmed/21715664|https://www.ncbi.nlm.nih.gov/pubmed/32417428,19770486|20127859|21715664|32417428,,
5,322354,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100559,UGT2B38,https://ctdbase.org/detail.go?type=gene&acc=100559,,,100559.0,Ugt2b38,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of UGT2B38 mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
6,322355,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7363,UGT2B4,https://ctdbase.org/detail.go?type=gene&acc=7363,,,7363.0,UGT2B4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of UGT2B4 3' utr|benzo(a)pyrene results in decreased methylation of UGT2B4 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
7,322356,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7363,UGT2B4,https://ctdbase.org/detail.go?type=gene&acc=7363,,,7363.0,UGT2B4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of UGT2B4 mRNA,,,PMID:20106945|PMID:21632981|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|21632981|32234424,,
8,322357,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22238,UGT2B5,https://ctdbase.org/detail.go?type=gene&acc=22238,,,22238.0,Ugt2b5,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of UGT2B5 mRNA,,,PMID:19770486|PMID:20127859|PMID:3117546,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/20127859|https://www.ncbi.nlm.nih.gov/pubmed/3117546,19770486|20127859|3117546,,
9,322358,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7364,UGT2B7,https://ctdbase.org/detail.go?type=gene&acc=7364,,,7364.0,UGT2B7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of UGT2B7 mRNA,,,PMID:16545412,https://www.ncbi.nlm.nih.gov/pubmed/16545412,16545412,,
10,322359,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,179464,UGT-33,https://ctdbase.org/detail.go?type=gene&acc=179464,,,179464.0,ugt-33,6239.0,Caenorhabditis elegans,Benzo(a)pyrene results in increased expression of UGT-33 mRNA,,,PMID:33420596,https://www.ncbi.nlm.nih.gov/pubmed/33420596,33420596,,
11,322360,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,184266,UGT-36,https://ctdbase.org/detail.go?type=gene&acc=184266,,,184266.0,ugt-36,6239.0,Caenorhabditis elegans,Benzo(a)pyrene results in increased expression of UGT-36 mRNA,,,PMID:33420596,https://www.ncbi.nlm.nih.gov/pubmed/33420596,33420596,,
12,322361,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,133688,UGT3A1,https://ctdbase.org/detail.go?type=gene&acc=133688,,,133688.0,UGT3A1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of UGT3A1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
13,322985,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6868,ADAM17,https://ctdbase.org/detail.go?type=gene&acc=6868,,,6868.0,ADAM17,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ADAM17 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
14,322986,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8749,ADAM18,https://ctdbase.org/detail.go?type=gene&acc=8749,,,8749.0,ADAM18,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ADAM18 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
15,322987,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8749,ADAM18,https://ctdbase.org/detail.go?type=gene&acc=8749,,,8749.0,ADAM18,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ADAM18 mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
16,322988,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8728,ADAM19,https://ctdbase.org/detail.go?type=gene&acc=8728,,,8728.0,ADAM19,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of ADAM19 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
17,322989,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8728,ADAM19,https://ctdbase.org/detail.go?type=gene&acc=8728,,,8728.0,ADAM19,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of ADAM19 exon|benzo(a)pyrene results in increased methylation of ADAM19 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
18,323156,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,144165,PRICKLE1,https://ctdbase.org/detail.go?type=gene&acc=144165,,,144165.0,PRICKLE1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PRICKLE1 mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
19,323157,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,166336,PRICKLE2,https://ctdbase.org/detail.go?type=gene&acc=166336,,,166336.0,PRICKLE2,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of PRICKLE2 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
20,323158,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,166336,PRICKLE2,https://ctdbase.org/detail.go?type=gene&acc=166336,,,166336.0,PRICKLE2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PRICKLE2 promoter|benzo(a)pyrene affects the methylation of PRICKLE2 exon|benzo(a)pyrene affects the methylation of PRICKLE2 5' utr|benzo(a)pyrene results in increased methylation of PRICKLE2 3' utr|benzo(a)pyrene results in decreased methylation of PRICKLE2 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
21,323159,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,166336,PRICKLE2,https://ctdbase.org/detail.go?type=gene&acc=166336,,,166336.0,PRICKLE2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of PRICKLE2 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
22,323160,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,166336,PRICKLE2,https://ctdbase.org/detail.go?type=gene&acc=166336,,,166336.0,PRICKLE2,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of PRICKLE2 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
23,325487,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55803,ADAP2,https://ctdbase.org/detail.go?type=gene&acc=55803,,,55803.0,ADAP2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to ADAP2 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
24,326623,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,118,ADD1,https://ctdbase.org/detail.go?type=gene&acc=118,,,118.0,ADD1,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of ADD1 mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
25,326974,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,378834,PROM1B,https://ctdbase.org/detail.go?type=gene&acc=378834,,,378834.0,prom1b,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in increased expression of PROM1B mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
26,326975,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,150696,PROM2,https://ctdbase.org/detail.go?type=gene&acc=150696,,,150696.0,PROM2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PROM2 exon|benzo(a)pyrene results in decreased methylation of PROM2 promoter|benzo(a)pyrene results in increased methylation of PROM2 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
27,326976,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,150696,PROM2,https://ctdbase.org/detail.go?type=gene&acc=150696,,,150696.0,PROM2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to PROM2 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
28,326977,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5626,PROP1,https://ctdbase.org/detail.go?type=gene&acc=5626,,,5626.0,PROP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PROP1 promoter|benzo(a)pyrene affects the methylation of PROP1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
29,326978,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9692,PRORP,https://ctdbase.org/detail.go?type=gene&acc=9692,,,9692.0,PRORP,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PRORP intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
30,326979,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9692,PRORP,https://ctdbase.org/detail.go?type=gene&acc=9692,,,9692.0,PRORP,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PRORP mRNA,,,PMID:20064835|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20064835|21632981,,
31,326980,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,67939,PRORSD1,https://ctdbase.org/detail.go?type=gene&acc=67939,,,67939.0,Prorsd1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PRORSD1 mRNA,,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
32,327613,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25766,PRPF40B,https://ctdbase.org/detail.go?type=gene&acc=25766,,,25766.0,PRPF40B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PRPF40B promoter|benzo(a)pyrene affects the methylation of PRPF40B 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
33,327824,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5630,PRPH,https://ctdbase.org/detail.go?type=gene&acc=5630,,,5630.0,PRPH,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to PRPH promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
34,327825,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5630,PRPH,https://ctdbase.org/detail.go?type=gene&acc=5630,,,5630.0,PRPH,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of PRPH protein|benzo(a)pyrene results in decreased expression of PRPH mrna|sodium arsenate promotes the reaction [benzo(a)pyrene results in decreased expression of PRPH protein]|sodium arsenate promotes the reaction [benzo(a)pyrene results in decreased expression of PRPH mrna],,,PMID:16456883,https://www.ncbi.nlm.nih.gov/pubmed/16456883,16456883,,
35,327826,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PRPS1 exon|benzo(a)pyrene affects the methylation of PRPS1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
36,327827,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PRPS1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
37,329637,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5396,PRRX1,https://ctdbase.org/detail.go?type=gene&acc=5396,,,5396.0,PRRX1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PRRX1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
38,329638,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5396,PRRX1,https://ctdbase.org/detail.go?type=gene&acc=5396,,,5396.0,PRRX1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PRRX1 exon|benzo(a)pyrene affects the methylation of PRRX1 promoter|benzo(a)pyrene results in increased methylation of PRRX1 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
39,329639,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5396,PRRX1,https://ctdbase.org/detail.go?type=gene&acc=5396,,,5396.0,PRRX1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PRRX1 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
40,329640,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5396,PRRX1,https://ctdbase.org/detail.go?type=gene&acc=5396,,,5396.0,PRRX1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PRRX1 mRNA,,,PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22610609,22610609,,
41,329641,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51450,PRRX2,https://ctdbase.org/detail.go?type=gene&acc=51450,,,51450.0,PRRX2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PRRX2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
42,329642,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51450,PRRX2,https://ctdbase.org/detail.go?type=gene&acc=51450,,,51450.0,PRRX2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PRRX2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
43,329643,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5644,PRSS1,https://ctdbase.org/detail.go?type=gene&acc=5644,,,5644.0,PRSS1,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in increased expression of PRSS1 mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
44,330459,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,151,ADRA2B,https://ctdbase.org/detail.go?type=gene&acc=151,,,151.0,ADRA2B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ADRA2B mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
45,330460,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,152,ADRA2C,https://ctdbase.org/detail.go?type=gene&acc=152,,,152.0,ADRA2C,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ADRA2C exon|benzo(a)pyrene results in increased methylation of ADRA2C promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
46,330461,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,152,ADRA2C,https://ctdbase.org/detail.go?type=gene&acc=152,,,152.0,ADRA2C,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ADRA2C mRNA,,,PMID:21632981|PMID:22316170|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291,21632981|22316170|26238291,,
47,330462,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,153,ADRB1,https://ctdbase.org/detail.go?type=gene&acc=153,,,153.0,ADRB1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ADRB1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
48,330463,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,153,ADRB1,https://ctdbase.org/detail.go?type=gene&acc=153,,,153.0,ADRB1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ADRB1 mRNA,,,PMID:22228805|PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/22610609,22228805|22610609,,
49,330464,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,9606.0,Homo sapiens (human),ADRB2 protein promotes the reaction [benzo(a)pyrene results in increased transport of calcium]|[benzo(a)pyrene binds to ADRB2 protein] which results in increased transport of calcium|benzo(a)pyrene binds to ADRB2 protein|adrb2 protein results in increased susceptibility to benzo(a)pyrene,,,PMID:22167199,https://www.ncbi.nlm.nih.gov/pubmed/22167199,22167199,,
50,330465,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ADRB2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
51,330466,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with dextran sulfate] results in increased expression of ADRB2 mRNA,,,PMID:26271895,https://www.ncbi.nlm.nih.gov/pubmed/26271895,26271895,,
52,330467,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10451,VAV3,https://ctdbase.org/detail.go?type=gene&acc=10451,,,10451.0,VAV3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene affects the expression of VAV3 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
53,330468,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10451,VAV3,https://ctdbase.org/detail.go?type=gene&acc=10451,,,10451.0,VAV3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of VAV3 mRNA,,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
54,322990,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,958,CD40,https://ctdbase.org/detail.go?type=gene&acc=958,,,958.0,CD40,9541.0,Macaca fascicularis (crab-eating macaque),Clofibrate results in decreased expression of CD40 mRNA,,,PMID:16081524,https://www.ncbi.nlm.nih.gov/pubmed/16081524,16081524,,
55,322991,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,12509,CD59A,https://ctdbase.org/detail.go?type=gene&acc=12509,,,12509.0,Cd59a,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of CD59A mrna]|[clofibrate co-treated with acetaminophen] affects the expression of CD59A mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
56,322992,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,922,CD5L,https://ctdbase.org/detail.go?type=gene&acc=922,,,922.0,CD5L,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of CD5L mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of CD5L mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
57,322993,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,972,CD74,https://ctdbase.org/detail.go?type=gene&acc=972,,,972.0,CD74,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of CD74 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of CD74 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
58,323342,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9541.0,Macaca fascicularis (crab-eating macaque),Clofibrate results in decreased expression of CDK2 mRNA,,,PMID:16081524,https://www.ncbi.nlm.nih.gov/pubmed/16081524,16081524,,
59,323343,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of CDK2 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of CDK2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
60,323344,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,10263,CDK2AP2,https://ctdbase.org/detail.go?type=gene&acc=10263,,,10263.0,CDK2AP2,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of CDK2AP2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
61,323345,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),CREBBP protein inhibits the reaction [clofibrate results in decreased expression of CDK4 protein]|ncoa1 protein inhibits the reaction [clofibrate results in decreased expression of CDK4 protein]|clofibrate results in decreased expression of CDK4 protein,,,PMID:21080969,https://www.ncbi.nlm.nih.gov/pubmed/21080969,21080969,,
62,323346,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1020,CDK5,https://ctdbase.org/detail.go?type=gene&acc=1020,,,1020.0,CDK5,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of CDK5 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
63,323347,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,8941,CDK5R2,https://ctdbase.org/detail.go?type=gene&acc=8941,,,8941.0,CDK5R2,34765.0,Oikopleura dioica,Clofibrate results in increased expression of CDK5R2 mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
64,323348,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,80279,CDK5RAP3,https://ctdbase.org/detail.go?type=gene&acc=80279,,,80279.0,CDK5RAP3,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of CDK5RAP3 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of CDK5RAP3 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
65,323823,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,29927,SEC61A1,https://ctdbase.org/detail.go?type=gene&acc=29927,,,29927.0,SEC61A1,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of SEC61A1 mrna|clofibrate results in decreased expression of SEC61A1 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of SEC61A1 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
66,323824,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,55176,SEC61A2,https://ctdbase.org/detail.go?type=gene&acc=55176,,,55176.0,SEC61A2,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of SEC61A2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
67,324310,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,51156,SERPINA10,https://ctdbase.org/detail.go?type=gene&acc=51156,,,51156.0,SERPINA10,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of SERPINA10 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of SERPINA10 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
68,324311,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,51156,SERPINA10,https://ctdbase.org/detail.go?type=gene&acc=51156,,,51156.0,SERPINA10,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of SERPINA10 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
69,324312,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,145264,SERPINA12,https://ctdbase.org/detail.go?type=gene&acc=145264,,,145264.0,SERPINA12,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of SERPINA12 mRNA,,,PMID:33549593,https://www.ncbi.nlm.nih.gov/pubmed/33549593,33549593,,
70,324313,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,20700,SERPINA1A,https://ctdbase.org/detail.go?type=gene&acc=20700,,,20700.0,Serpina1a,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of SERPINA1A mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
71,324791,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,25792,CIZ1,https://ctdbase.org/detail.go?type=gene&acc=25792,,,25792.0,CIZ1,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of CIZ1 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
72,324792,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,26586,CKAP2,https://ctdbase.org/detail.go?type=gene&acc=26586,,,26586.0,CKAP2,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of CKAP2 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of CKAP2 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
73,324793,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1152,CKB,https://ctdbase.org/detail.go?type=gene&acc=1152,,,1152.0,CKB,34765.0,Oikopleura dioica,Clofibrate results in decreased expression of CKB mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
74,324794,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1158,CKM,https://ctdbase.org/detail.go?type=gene&acc=1158,,,1158.0,CKM,34765.0,Oikopleura dioica,Clofibrate results in decreased expression of CKM mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
75,324795,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1160,CKMT2,https://ctdbase.org/detail.go?type=gene&acc=1160,,,1160.0,CKMT2,34765.0,Oikopleura dioica,Clofibrate results in decreased expression of CKMT2 mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
76,324967,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1327,COX4I1,https://ctdbase.org/detail.go?type=gene&acc=1327,,,1327.0,COX4I1,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of COX4I1 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
77,324968,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,165530,CLEC4F,https://ctdbase.org/detail.go?type=gene&acc=165530,,,165530.0,CLEC4F,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of CLEC4F mrna]|[clofibrate co-treated with acetaminophen] affects the expression of CLEC4F mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
78,324969,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,181855,CLEC-52,https://ctdbase.org/detail.go?type=gene&acc=181855,,,181855.0,clec-52,6239.0,Caenorhabditis elegans,Clofibrate results in increased expression of CLEC-52 mRNA,,,PMID:16168746,https://www.ncbi.nlm.nih.gov/pubmed/16168746,16168746,,
79,324970,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,9022,CLIC3,https://ctdbase.org/detail.go?type=gene&acc=9022,,,9022.0,CLIC3,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of CLIC3 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
80,324971,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1201,CLN3,https://ctdbase.org/detail.go?type=gene&acc=1201,,,1201.0,CLN3,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of CLN3 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
81,324972,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1203,CLN5,https://ctdbase.org/detail.go?type=gene&acc=1203,,,1203.0,CLN5,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of CLN5 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
82,325666,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,6503,SLA,https://ctdbase.org/detail.go?type=gene&acc=6503,,,6503.0,SLA,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of SLA mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of SLA mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
83,325667,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,6554,SLC10A1,https://ctdbase.org/detail.go?type=gene&acc=6554,,,6554.0,SLC10A1,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of SLC10A1 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of SLC10A1 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of SLC10A1 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
84,325668,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,6554,SLC10A1,https://ctdbase.org/detail.go?type=gene&acc=6554,,,6554.0,SLC10A1,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of SLC10A1 mRNA,,,PMID:28973556,https://www.ncbi.nlm.nih.gov/pubmed/28973556,28973556,,
85,325669,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,6555,SLC10A2,https://ctdbase.org/detail.go?type=gene&acc=6555,,,6555.0,SLC10A2,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of SLC10A2 mRNA,,,PMID:25270620|PMID:28973556,https://www.ncbi.nlm.nih.gov/pubmed/25270620|https://www.ncbi.nlm.nih.gov/pubmed/28973556,25270620|28973556,,
86,325670,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,6555,SLC10A2,https://ctdbase.org/detail.go?type=gene&acc=6555,,,6555.0,SLC10A2,10090.0,Mus musculus (house mouse),[PPARA gene mutant form results in increased susceptibility to clofibrate] which results in increased expression of SLC10A2 mRNA,,,PMID:29175453,https://www.ncbi.nlm.nih.gov/pubmed/29175453,29175453,,
87,325671,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,6556,SLC11A1,https://ctdbase.org/detail.go?type=gene&acc=6556,,,6556.0,SLC11A1,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of SLC11A1 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of SLC11A1 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
88,327157,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1445,CSK,https://ctdbase.org/detail.go?type=gene&acc=1445,,,1445.0,CSK,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of CSK mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
89,327158,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1453,CSNK1D,https://ctdbase.org/detail.go?type=gene&acc=1453,,,1453.0,CSNK1D,9541.0,Macaca fascicularis (crab-eating macaque),Clofibrate results in decreased expression of CSNK1D mRNA,,,PMID:16081524,https://www.ncbi.nlm.nih.gov/pubmed/16081524,16081524,,
90,327159,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1453,CSNK1D,https://ctdbase.org/detail.go?type=gene&acc=1453,,,1453.0,CSNK1D,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of CSNK1D mrna|clofibrate affects the expression of CSNK1D mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of CSNK1D mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
91,327160,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1459,CSNK2A2,https://ctdbase.org/detail.go?type=gene&acc=1459,,,1459.0,CSNK2A2,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of CSNK2A2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
92,327161,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1460,CSNK2B,https://ctdbase.org/detail.go?type=gene&acc=1460,,,1460.0,CSNK2B,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of CSNK2B mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
93,327162,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1465,CSRP1,https://ctdbase.org/detail.go?type=gene&acc=1465,,,1465.0,CSRP1,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of CSRP1 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
94,328349,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,27044,SND1,https://ctdbase.org/detail.go?type=gene&acc=27044,,,27044.0,SND1,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of SND1 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
95,329493,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10090.0,Mus musculus (house mouse),[clofibrate results in increased activity of PPARA protein] which results in increased expression of CYP4A14 mrna|ppara protein affects the reaction [clofibrate results in increased expression of CYP4A14 mrna],,,PMID:22496397,https://www.ncbi.nlm.nih.gov/pubmed/22496397,22496397,,
96,329494,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of CYP4A14 mRNA,,,PMID:15919853|PMID:16467456|PMID:17585979|PMID:17627975|PMID:18488193|PMID:19144771|PMID:22342832|PMID:22496397|PMID:25270620|PMID:30629241,https://www.ncbi.nlm.nih.gov/pubmed/15919853|https://www.ncbi.nlm.nih.gov/pubmed/16467456|https://www.ncbi.nlm.nih.gov/pubmed/17585979|https://www.ncbi.nlm.nih.gov/pubmed/17627975|https://www.ncbi.nlm.nih.gov/pubmed/18488193|https://www.ncbi.nlm.nih.gov/pubmed/19144771|https://www.ncbi.nlm.nih.gov/pubmed/22342832|https://www.ncbi.nlm.nih.gov/pubmed/22496397|https://www.ncbi.nlm.nih.gov/pubmed/25270620|https://www.ncbi.nlm.nih.gov/pubmed/30629241,15919853|16467456|17585979|17627975|18488193|19144771|22342832|22496397|25270620|30629241,,
97,329495,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10090.0,Mus musculus (house mouse),PPARA promotes the reaction [clofibrate results in increased expression of CYP4A14 mrna],,,PMID:16467456,https://www.ncbi.nlm.nih.gov/pubmed/16467456,16467456,,
98,329496,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10116.0,Rattus norvegicus (Norway rat),Clofibrate results in increased expression of CYP4A14 mRNA,,,PMID:18246545|PMID:18670166,https://www.ncbi.nlm.nih.gov/pubmed/18246545|https://www.ncbi.nlm.nih.gov/pubmed/18670166,18246545|18670166,,
99,329497,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,24306,CYP4A2,https://ctdbase.org/detail.go?type=gene&acc=24306,,,24306.0,Cyp4a2,10090.0,Mus musculus (house mouse),PPARA affects the reaction [clofibrate results in increased expression of CYP4A2 mrna]|clofibrate results in increased expression of CYP4A2 mRNA,,,PMID:10787435,https://www.ncbi.nlm.nih.gov/pubmed/10787435,10787435,,
100,329498,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,24306,CYP4A2,https://ctdbase.org/detail.go?type=gene&acc=24306,,,24306.0,Cyp4a2,10116.0,Rattus norvegicus (Norway rat),Clofibrate results in increased expression of CYP4A2 mRNA,,,PMID:11328961|PMID:2766933|PMID:32741897,https://www.ncbi.nlm.nih.gov/pubmed/11328961|https://www.ncbi.nlm.nih.gov/pubmed/2766933|https://www.ncbi.nlm.nih.gov/pubmed/32741897,11328961|2766933|32741897,,
101,330140,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,6754,SSTR4,https://ctdbase.org/detail.go?type=gene&acc=6754,,,6754.0,SSTR4,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of SSTR4 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
102,330141,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,117178,SSX2IP,https://ctdbase.org/detail.go?type=gene&acc=117178,,,117178.0,SSX2IP,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of SSX2IP mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
103,330631,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,412,STS,https://ctdbase.org/detail.go?type=gene&acc=412,,,412.0,STS,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of STS mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
104,330632,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,6809,STX3,https://ctdbase.org/detail.go?type=gene&acc=6809,,,6809.0,STX3,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of STX3 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
105,330633,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,8803,SUCLA2,https://ctdbase.org/detail.go?type=gene&acc=8803,,,8803.0,SUCLA2,10116.0,Rattus norvegicus (Norway rat),Clofibrate results in increased expression of SUCLA2 protein,,,PMID:16470657,https://www.ncbi.nlm.nih.gov/pubmed/16470657,16470657,,
106,330634,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,8802,SUCLG1,https://ctdbase.org/detail.go?type=gene&acc=8802,,,8802.0,SUCLG1,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of SUCLG1 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of SUCLG1 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
107,330635,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,8802,SUCLG1,https://ctdbase.org/detail.go?type=gene&acc=8802,,,8802.0,SUCLG1,34765.0,Oikopleura dioica,Clofibrate results in decreased expression of SUCLG1 mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
108,330636,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,8802,SUCLG1,https://ctdbase.org/detail.go?type=gene&acc=8802,,,8802.0,SUCLG1,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of SUCLG1 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
109,330637,2801,BindingDB,Clomipramine,77970,"3-(2-chloranyl-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77970,774,Orf1a protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=774,,,,,,,,,,PMID:32852058|DOI:10.1002/med.21724,https://www.ncbi.nlm.nih.gov/pubmed/32852058|https://doi.org/10.1002/med.21724,32852058,10.1002/med.21724,
110,330638,2801,BindingDB,Clomipramine,77970,"3-(2-chloranyl-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77970,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,,,PMID:32852058|DOI:10.1002/med.21724,https://www.ncbi.nlm.nih.gov/pubmed/32852058|https://doi.org/10.1002/med.21724,32852058,10.1002/med.21724,
111,330639,2801,Drug Gene Interaction database (DGIdb),Clomipramine,,CLOMIPRAMINE,https://www.dgidb.org/drugs/rxcui:2597,,SLC6A2,https://www.dgidb.org/genes/hgnc:11048,,,6530.0,SLC6A2,9606.0,Homo sapiens (human),,,,,,,,
112,321374,2811,Toxin and Toxin Target Database (T3DB),Clotiazepam,T3D3049,Clotiazepam,http://www.t3db.ca/toxins/T3D3049,BE0003598,Gamma-aminobutyric acid receptor subunit rho-2,http://www.t3db.ca/biodb/bio_entities/BE0003598,P28476,Gamma-aminobutyric acid receptor subunit rho-2,2570.0,GABRR2,9606.0,Homo sapiens (human),,,,PMID:6738302|PMID:2867566|PMID:18855614,https://www.ncbi.nlm.nih.gov/pubmed/6738302|https://www.ncbi.nlm.nih.gov/pubmed/2867566|https://www.ncbi.nlm.nih.gov/pubmed/18855614,6738302|2867566|18855614,,
113,321375,2811,Toxin and Toxin Target Database (T3DB),Clotiazepam,T3D3049,Clotiazepam,http://www.t3db.ca/toxins/T3D3049,BE0003619,Gamma-aminobutyric acid receptor subunit rho-3,http://www.t3db.ca/biodb/bio_entities/BE0003619,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,200959.0,GABRR3,9606.0,Homo sapiens (human),,,,PMID:6738302|PMID:2867566|PMID:18855614,https://www.ncbi.nlm.nih.gov/pubmed/6738302|https://www.ncbi.nlm.nih.gov/pubmed/2867566|https://www.ncbi.nlm.nih.gov/pubmed/18855614,6738302|2867566|18855614,,
114,321376,2811,Toxin and Toxin Target Database (T3DB),Clotiazepam,T3D3049,Clotiazepam,http://www.t3db.ca/toxins/T3D3049,BE0000736,Translocator protein,http://www.t3db.ca/biodb/bio_entities/BE0000736,P30536,Translocator protein,706.0,TSPO,9606.0,Homo sapiens (human),"Clotiazepam acts at the benzodiazepine receptors (BZD). this agonizes the action of GABA, increasing the frequency of opening of the channel chlorinates and penetration of the ions chlorinates through the ionophore. increase in membrane polarization decreases the probability of discharge of neurons.",,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
115,321377,2811,Toxin and Toxin Target Database (T3DB),Clotiazepam,T3D3049,Clotiazepam,http://www.t3db.ca/toxins/T3D3049,BE0004797,GABA-A receptor (anion channel),http://www.t3db.ca/biodb/bio_entities/BE0004797,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),,,,,,,,
116,321378,2811,Toxin and Toxin Target Database (T3DB),Clotiazepam,T3D3049,Clotiazepam,http://www.t3db.ca/toxins/T3D3049,BE0004797,GABA-A receptor (anion channel),http://www.t3db.ca/biodb/bio_entities/BE0004797,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606.0,Homo sapiens (human),,,,,,,,
117,321379,2811,Toxin and Toxin Target Database (T3DB),Clotiazepam,T3D3049,Clotiazepam,http://www.t3db.ca/toxins/T3D3049,BE0004797,GABA-A receptor (anion channel),http://www.t3db.ca/biodb/bio_entities/BE0004797,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),,,,,,,,
118,321694,2811,ChEMBL,Clotiazepam,CHEMBL1697737,CLOTIAZEPAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697737/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P28472,Gamma-aminobutyric acid receptor subunit beta-3,2562.0,GABRB3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:16272224|PMID:18604239,https://www.ncbi.nlm.nih.gov/pubmed/16272224|https://www.ncbi.nlm.nih.gov/pubmed/18604239,16272224|18604239,,
119,321695,2811,ChEMBL,Clotiazepam,CHEMBL1697737,CLOTIAZEPAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697737/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558.0,GABRA5,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:16272224|PMID:18604239,https://www.ncbi.nlm.nih.gov/pubmed/16272224|https://www.ncbi.nlm.nih.gov/pubmed/18604239,16272224|18604239,,
120,321696,2811,ChEMBL,Clotiazepam,CHEMBL1697737,CLOTIAZEPAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697737/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:16272224|PMID:18604239,https://www.ncbi.nlm.nih.gov/pubmed/16272224|https://www.ncbi.nlm.nih.gov/pubmed/18604239,16272224|18604239,,
121,321697,2811,ChEMBL,Clotiazepam,CHEMBL1697737,CLOTIAZEPAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697737/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:16272224|PMID:18604239,https://www.ncbi.nlm.nih.gov/pubmed/16272224|https://www.ncbi.nlm.nih.gov/pubmed/18604239,16272224|18604239,,
122,321880,2811,ChEMBL,Clotiazepam,CHEMBL1697737,CLOTIAZEPAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697737/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,2559.0,GABRA6,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:16272224|PMID:18604239,https://www.ncbi.nlm.nih.gov/pubmed/16272224|https://www.ncbi.nlm.nih.gov/pubmed/18604239,16272224|18604239,,
123,321881,2811,ChEMBL,Clotiazepam,CHEMBL1697737,CLOTIAZEPAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697737/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,2565.0,GABRG1,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:16272224|PMID:18604239,https://www.ncbi.nlm.nih.gov/pubmed/16272224|https://www.ncbi.nlm.nih.gov/pubmed/18604239,16272224|18604239,,
124,321882,2811,ChEMBL,Clotiazepam,CHEMBL1697737,CLOTIAZEPAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697737/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567.0,GABRG3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:16272224|PMID:18604239,https://www.ncbi.nlm.nih.gov/pubmed/16272224|https://www.ncbi.nlm.nih.gov/pubmed/18604239,16272224|18604239,,
125,321883,2811,ChEMBL,Clotiazepam,CHEMBL1697737,CLOTIAZEPAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697737/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,55879.0,GABRQ,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:16272224|PMID:18604239,https://www.ncbi.nlm.nih.gov/pubmed/16272224|https://www.ncbi.nlm.nih.gov/pubmed/18604239,16272224|18604239,,
126,321884,2812,IUPHAR/BPS Guide to PHARMACOLOGY,Clotrimazole,2330,clotrimazole,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2330,384,KCa3.1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=384,O15554,Intermediate conductance calcium-activated potassium channel protein 4,3783.0,KCNN4,9606.0,Homo sapiens (human),Inhibition,pKd,6.41 - 7.62,PMID:9326665|PMID:9693050|PMID:9407042|PMID:10884437,https://www.ncbi.nlm.nih.gov/pubmed/9326665|https://www.ncbi.nlm.nih.gov/pubmed/9693050|https://www.ncbi.nlm.nih.gov/pubmed/9407042|https://www.ncbi.nlm.nih.gov/pubmed/10884437,9326665|9693050|9407042|10884437,,
127,322195,2895,DrugBank,Cyclobenzaprine,DB00924,Cyclobenzaprine,https://www.drugbank.ca/drugs/DB00924,BE0009343,UDP-glucuronosyltransferase 2B10,https://www.drugbank.ca/bio_entities/BE0009343,P36537,UDP-glucuronosyltransferase 2B10 ,7365.0,UGT2B10,9606.0,Homo sapiens (human),Substrate,,,PMID:28803208,https://www.ncbi.nlm.nih.gov/pubmed/28803208,28803208,,
128,322196,2895,DrugBank,Cyclobenzaprine,DB00924,Cyclobenzaprine,https://www.drugbank.ca/drugs/DB00924,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Substrate,,,PMID:30717459,https://www.ncbi.nlm.nih.gov/pubmed/30717459,30717459,,
129,322197,2895,Drug Gene Interaction database (DGIdb),Cyclobenzaprine,,CYCLOBENZAPRINE,https://www.dgidb.org/drugs/rxcui:21949,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
130,322198,2895,Drug Gene Interaction database (DGIdb),Cyclobenzaprine,,CYCLOBENZAPRINE,https://www.dgidb.org/drugs/rxcui:21949,,APEX1,https://www.dgidb.org/genes/hgnc:587,,,328.0,APEX1,9606.0,Homo sapiens (human),,,,,,,,
131,322199,2905,DrugBank,Cyclopentolate,DB00979,Cyclopentolate,https://www.drugbank.ca/drugs/DB00979,BE0000092,Muscarinic acetylcholine receptor M1,https://www.drugbank.ca/bio_entities/BE0000092,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Antagonist,,,PMID:1848211|PMID:17992517|PMID:10025113|PMID:19486927|PMID:29085421,https://www.ncbi.nlm.nih.gov/pubmed/1848211|https://www.ncbi.nlm.nih.gov/pubmed/17992517|https://www.ncbi.nlm.nih.gov/pubmed/10025113|https://www.ncbi.nlm.nih.gov/pubmed/19486927|https://www.ncbi.nlm.nih.gov/pubmed/29085421,1848211|17992517|10025113|19486927|29085421,,
132,322835,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),CYP3A4 protein results in increased susceptibility to cyclophosphamide,,,PMID:26718876|PMID:30500380,https://www.ncbi.nlm.nih.gov/pubmed/26718876|https://www.ncbi.nlm.nih.gov/pubmed/30500380,26718876|30500380,,
133,322836,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,10090.0,Mus musculus (house mouse),Cyclophosphamide results in decreased activity of CYP3A4 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
134,322837,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606.0,Homo sapiens (human),CYP3A5 protein affects the metabolism of cyclophosphamide|cyp3a5 gene affects the susceptibility to [carmustine co-treated with cyclophosphamide co-treated with cisplatin]|cyp3a5 gene polymorphism affects the susceptibility to cyclophosphamide,,,PMID:16087946,https://www.ncbi.nlm.nih.gov/pubmed/16087946,16087946,,
135,322838,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606.0,Homo sapiens (human),CYP3A5 results in increased activity of cyclophosphamide,,,PMID:8717162,https://www.ncbi.nlm.nih.gov/pubmed/8717162,8717162,,
136,322839,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,1634,DCN,https://ctdbase.org/detail.go?type=gene&acc=1634,,,1634.0,DCN,10090.0,Mus musculus (house mouse),DCN protein inhibits the reaction [TGFB1 protein results in decreased susceptibility to [cyclophosphamide co-treated with cisplatin co-treated with melphalan co-treated with thiotepa]],,,PMID:9509296,https://www.ncbi.nlm.nih.gov/pubmed/9509296,9509296,,
137,325134,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,116113,FOXP4,https://ctdbase.org/detail.go?type=gene&acc=116113,,,116113.0,FOXP4,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in decreased expression of FOXP4 mRNA,,,PMID:27281708,https://www.ncbi.nlm.nih.gov/pubmed/27281708,27281708,,
138,325135,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,2358,FPR2,https://ctdbase.org/detail.go?type=gene&acc=2358,,,2358.0,FPR2,10090.0,Mus musculus (house mouse),Cyclophosphamide results in increased expression of FPR2 mRNA,,,PMID:15331540,https://www.ncbi.nlm.nih.gov/pubmed/15331540,15331540,,
139,325136,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6624,FSCN1,https://ctdbase.org/detail.go?type=gene&acc=6624,,,6624.0,FSCN1,9606.0,Homo sapiens (human),Cyclophosphamide results in increased expression of FSCN1 mRNA,,,PMID:17403535,https://www.ncbi.nlm.nih.gov/pubmed/17403535,17403535,,
140,325137,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,9606.0,Homo sapiens (human),Cyclophosphamide results in increased expression of FSHB protein,,,PMID:6788612,https://www.ncbi.nlm.nih.gov/pubmed/6788612,6788612,,
141,325138,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased expression of FSHB protein|cilostazol inhibits the reaction [cyclophosphamide results in increased expression of FSHB protein],,,PMID:32456565,https://www.ncbi.nlm.nih.gov/pubmed/32456565,32456565,,
142,325139,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in decreased secretion of FSHB protein,,,PMID:25446862|PMID:32197949,https://www.ncbi.nlm.nih.gov/pubmed/25446862|https://www.ncbi.nlm.nih.gov/pubmed/32197949,25446862|32197949,,
143,325140,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116.0,Rattus norvegicus (Norway rat),Sacubitril and valsartan sodium hydrate drug combination inhibits the reaction [cyclophosphamide results in decreased secretion of FSHB protein]|valsartan inhibits the reaction [cyclophosphamide results in decreased secretion of FSHB protein],,,PMID:32197949,https://www.ncbi.nlm.nih.gov/pubmed/32197949,32197949,,
144,325141,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,2492,FSHR,https://ctdbase.org/detail.go?type=gene&acc=2492,,,2492.0,FSHR,10090.0,Mus musculus (house mouse),Coenzyme Q10 inhibits the reaction [cyclophosphamide results in decreased expression of FSHR mrna]|cyclophosphamide results in decreased expression of FSHR mRNA,,,PMID:31557371,https://www.ncbi.nlm.nih.gov/pubmed/31557371,31557371,,
145,328019,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090.0,Mus musculus (house mouse),Cyclophosphamide inhibits the reaction [paraquat results in increased expression of ICAM1 mrna],,,PMID:36031164,https://www.ncbi.nlm.nih.gov/pubmed/36031164,36031164,,
146,328020,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090.0,Mus musculus (house mouse),ICAM1 protein affects the susceptibility to cyclophosphamide,,,PMID:11591119,https://www.ncbi.nlm.nih.gov/pubmed/11591119,11591119,,
147,328021,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3385,ICAM3,https://ctdbase.org/detail.go?type=gene&acc=3385,,,3385.0,ICAM3,9606.0,Homo sapiens (human),Cyclophosphamide results in decreased expression of ICAM3 mRNA,,,PMID:17403535,https://www.ncbi.nlm.nih.gov/pubmed/17403535,17403535,,
148,328022,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3398,ID2,https://ctdbase.org/detail.go?type=gene&acc=3398,,,3398.0,ID2,9606.0,Homo sapiens (human),Cyclophosphamide metabolite results in decreased expression of ID2 mRNA,,,PMID:24356939,https://www.ncbi.nlm.nih.gov/pubmed/24356939,24356939,,
149,328023,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3422,IDI1,https://ctdbase.org/detail.go?type=gene&acc=3422,,,3422.0,IDI1,9606.0,Homo sapiens (human),Cyclophosphamide metabolite results in increased expression of IDI1 mRNA,,,PMID:24356939,https://www.ncbi.nlm.nih.gov/pubmed/24356939,24356939,,
150,328024,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3620,IDO1,https://ctdbase.org/detail.go?type=gene&acc=3620,,,3620.0,IDO1,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased expression of and results in increased activity of IDO1 protein|quercetin inhibits the reaction [cyclophosphamide results in increased expression of and results in increased activity of IDO1 protein]|quercetin inhibits the reaction [cyclophosphamide results in increased activity of IDO1 protein],,,PMID:35906875,https://www.ncbi.nlm.nih.gov/pubmed/35906875,35906875,,
151,328025,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3620,IDO1,https://ctdbase.org/detail.go?type=gene&acc=3620,,,3620.0,IDO1,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [cyclophosphamide results in increased expression of IDO1 protein]|cyclophosphamide results in increased expression of IDO1 protein,,,PMID:34748891,https://www.ncbi.nlm.nih.gov/pubmed/34748891,34748891,,
152,328026,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,8870,IER3,https://ctdbase.org/detail.go?type=gene&acc=8870,,,8870.0,IER3,9606.0,Homo sapiens (human),Cyclophosphamide metabolite results in decreased expression of IER3 mRNA,,,PMID:24356939,https://www.ncbi.nlm.nih.gov/pubmed/24356939,24356939,,
153,329211,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3603,IL16,https://ctdbase.org/detail.go?type=gene&acc=3603,,,3603.0,IL16,10090.0,Mus musculus (house mouse),Cyclophosphamide results in decreased expression of IL16 mRNA,,,PMID:21041162,https://www.ncbi.nlm.nih.gov/pubmed/21041162,21041162,,
154,329212,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3605,IL17A,https://ctdbase.org/detail.go?type=gene&acc=3605,,,3605.0,IL17A,10090.0,Mus musculus (house mouse),Cyclophosphamide results in decreased expression of IL17A protein,,,PMID:21880982|PMID:32151603,https://www.ncbi.nlm.nih.gov/pubmed/21880982|https://www.ncbi.nlm.nih.gov/pubmed/32151603,21880982|32151603,,
155,329213,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3605,IL17A,https://ctdbase.org/detail.go?type=gene&acc=3605,,,3605.0,IL17A,10090.0,Mus musculus (house mouse),Levamisole inhibits the reaction [cyclophosphamide results in decreased expression of IL17A protein]|fungal polysaccharides inhibits the reaction [cyclophosphamide results in decreased expression of IL17A protein],,,PMID:32151603,https://www.ncbi.nlm.nih.gov/pubmed/32151603,32151603,,
156,329214,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased expression of IL18 protein,,,PMID:18848347,https://www.ncbi.nlm.nih.gov/pubmed/18848347,18848347,,
157,329215,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),IL1A promoter polymorphism affects the susceptibility to cyclophosphamide,,,PMID:16636934,https://www.ncbi.nlm.nih.gov/pubmed/16636934,16636934,,
158,329216,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10090.0,Mus musculus (house mouse),[cyclophosphamide co-treated with methotrexate co-treated with fluorouracil] results in decreased expression of IL1A protein,,,PMID:31651976,https://www.ncbi.nlm.nih.gov/pubmed/31651976,31651976,,
159,329217,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10090.0,Mus musculus (house mouse),Cyclophosphamide results in increased expression of IL1A mRNA,,,PMID:15331540,https://www.ncbi.nlm.nih.gov/pubmed/15331540,15331540,,
160,330803,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,4033,IRAG2,https://ctdbase.org/detail.go?type=gene&acc=4033,,,4033.0,IRAG2,10090.0,Mus musculus (house mouse),Cyclophosphamide results in decreased expression of IRAG2 mRNA,,,PMID:21041162,https://www.ncbi.nlm.nih.gov/pubmed/21041162,21041162,,
161,330804,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,54396,IRGM2,https://ctdbase.org/detail.go?type=gene&acc=54396,,,54396.0,Irgm2,10090.0,Mus musculus (house mouse),Cyclophosphamide results in increased expression of IRGM2 mRNA,,,PMID:15331540,https://www.ncbi.nlm.nih.gov/pubmed/15331540,15331540,,
162,330805,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,3667,IRS1,https://ctdbase.org/detail.go?type=gene&acc=3667,,,3667.0,IRS1,9606.0,Homo sapiens (human),[doxorubicin co-treated with cyclophosphamide] affects the expression of IRS1 mRNA,,,PMID:16322899,https://www.ncbi.nlm.nih.gov/pubmed/16322899,16322899,,
163,322687,2995,Toxin and Toxin Target Database (T3DB),Desipramine,T3D2996,Desipramine,http://www.t3db.ca/toxins/T3D2996,BE0000289,Alpha-2A adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0000289,P08913,Alpha-2A adrenergic receptor,150.0,ADRA2A,9606.0,Homo sapiens (human),,,,PMID:7855217|PMID:9400006,https://www.ncbi.nlm.nih.gov/pubmed/7855217|https://www.ncbi.nlm.nih.gov/pubmed/9400006,7855217|9400006,,
164,322688,2995,Toxin and Toxin Target Database (T3DB),Desipramine,T3D2996,Desipramine,http://www.t3db.ca/toxins/T3D2996,BE0000045,Muscarinic acetylcholine receptor M3,http://www.t3db.ca/biodb/bio_entities/BE0000045,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),,,,PMID:7855217|PMID:8100134,https://www.ncbi.nlm.nih.gov/pubmed/7855217|https://www.ncbi.nlm.nih.gov/pubmed/8100134,7855217|8100134,,
165,322689,2995,Toxin and Toxin Target Database (T3DB),Desipramine,T3D2996,Desipramine,http://www.t3db.ca/toxins/T3D2996,BE0000405,Muscarinic acetylcholine receptor M4,http://www.t3db.ca/biodb/bio_entities/BE0000405,P08173,Muscarinic acetylcholine receptor M4,1132.0,CHRM4,9606.0,Homo sapiens (human),,,,PMID:7855217|PMID:8100134,https://www.ncbi.nlm.nih.gov/pubmed/7855217|https://www.ncbi.nlm.nih.gov/pubmed/8100134,7855217|8100134,,
166,322690,2995,Toxin and Toxin Target Database (T3DB),Desipramine,T3D2996,Desipramine,http://www.t3db.ca/toxins/T3D2996,BE0004863,Alpha-1 adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0004863,P35348,Alpha-1A adrenergic receptor,148.0,ADRA1A,9606.0,Homo sapiens (human),,,,PMID:7855217,https://www.ncbi.nlm.nih.gov/pubmed/7855217,7855217,,
167,322691,2995,Toxin and Toxin Target Database (T3DB),Desipramine,T3D2996,Desipramine,http://www.t3db.ca/toxins/T3D2996,BE0004863,Alpha-1 adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0004863,P35368,Alpha-1B adrenergic receptor,147.0,ADRA1B,9606.0,Homo sapiens (human),,,,PMID:7855217,https://www.ncbi.nlm.nih.gov/pubmed/7855217,7855217,,
168,322692,2995,Toxin and Toxin Target Database (T3DB),Desipramine,T3D2996,Desipramine,http://www.t3db.ca/toxins/T3D2996,BE0004863,Alpha-1 adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0004863,P25100,Alpha-1D adrenergic receptor,146.0,ADRA1D,9606.0,Homo sapiens (human),,,,PMID:7855217,https://www.ncbi.nlm.nih.gov/pubmed/7855217,7855217,,
169,321516,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,5337,PLD1,https://ctdbase.org/detail.go?type=gene&acc=5337,,,5337.0,PLD1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of PLD1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
170,321517,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,5338,PLD2,https://ctdbase.org/detail.go?type=gene&acc=5338,,,5338.0,PLD2,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of PLD2 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
171,321518,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,5341,PLEK,https://ctdbase.org/detail.go?type=gene&acc=5341,,,5341.0,PLEK,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of PLEK mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
172,321519,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,84725,PLEKHA8,https://ctdbase.org/detail.go?type=gene&acc=84725,,,84725.0,PLEKHA8,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of PLEKHA8 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
173,321520,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,55041,PLEKHB2,https://ctdbase.org/detail.go?type=gene&acc=55041,,,55041.0,PLEKHB2,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of PLEKHB2 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
174,321521,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,84069,PLEKHN1,https://ctdbase.org/detail.go?type=gene&acc=84069,,,84069.0,PLEKHN1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of PLEKHN1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
175,321522,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of PLIN1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
176,321523,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123.0,PLIN2,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of PLIN2 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
177,322200,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,51082,POLR1D,https://ctdbase.org/detail.go?type=gene&acc=51082,,,51082.0,POLR1D,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of POLR1D mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
178,322201,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,5438,POLR2I,https://ctdbase.org/detail.go?type=gene&acc=5438,,,5438.0,POLR2I,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of POLR2I mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
179,322202,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,55718,POLR3E,https://ctdbase.org/detail.go?type=gene&acc=55718,,,55718.0,POLR3E,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of POLR3E mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
180,324493,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,11159,RABL2A,https://ctdbase.org/detail.go?type=gene&acc=11159,,,11159.0,RABL2A,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of RABL2A mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
181,325132,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,9476,NAPSA,https://ctdbase.org/detail.go?type=gene&acc=9476,,,9476.0,NAPSA,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of NAPSA mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
182,325133,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,55226,NAT10,https://ctdbase.org/detail.go?type=gene&acc=55226,,,55226.0,NAT10,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of NAT10 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
183,327614,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,5274,SERPINI1,https://ctdbase.org/detail.go?type=gene&acc=5274,,,5274.0,SERPINI1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SERPINI1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
184,327615,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,29950,SERTAD1,https://ctdbase.org/detail.go?type=gene&acc=29950,,,29950.0,SERTAD1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SERTAD1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
185,327616,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,29946,SERTAD3,https://ctdbase.org/detail.go?type=gene&acc=29946,,,29946.0,SERTAD3,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SERTAD3 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
186,327617,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,27244,SESN1,https://ctdbase.org/detail.go?type=gene&acc=27244,,,27244.0,SESN1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SESN1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
187,327618,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,143686,SESN3,https://ctdbase.org/detail.go?type=gene&acc=143686,,,143686.0,SESN3,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SESN3 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
188,327619,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,91404,SESTD1,https://ctdbase.org/detail.go?type=gene&acc=91404,,,91404.0,SESTD1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SESTD1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
189,327620,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,23064,SETX,https://ctdbase.org/detail.go?type=gene&acc=23064,,,23064.0,SETX,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SETX mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
190,327621,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,51460,SFMBT1,https://ctdbase.org/detail.go?type=gene&acc=51460,,,51460.0,SFMBT1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SFMBT1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
191,327828,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,27352,SGSM3,https://ctdbase.org/detail.go?type=gene&acc=27352,,,27352.0,SGSM3,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SGSM3 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
192,327829,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,6456,SH3GL2,https://ctdbase.org/detail.go?type=gene&acc=6456,,,6456.0,SH3GL2,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SH3GL2 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
193,327830,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,9644,SH3PXD2A,https://ctdbase.org/detail.go?type=gene&acc=9644,,,9644.0,SH3PXD2A,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SH3PXD2A mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
194,327831,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,56961,SHD,https://ctdbase.org/detail.go?type=gene&acc=56961,,,56961.0,SHD,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SHD mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
195,327832,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,126669,SHE,https://ctdbase.org/detail.go?type=gene&acc=126669,,,126669.0,SHE,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SHE mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
196,327833,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,729956,SHISA7,https://ctdbase.org/detail.go?type=gene&acc=729956,,,729956.0,SHISA7,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SHISA7 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
197,328534,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,1836,SLC26A2,https://ctdbase.org/detail.go?type=gene&acc=1836,,,1836.0,SLC26A2,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SLC26A2 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
198,328535,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,1811,SLC26A3,https://ctdbase.org/detail.go?type=gene&acc=1811,,,1811.0,SLC26A3,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SLC26A3 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
199,328536,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,65010,SLC26A6,https://ctdbase.org/detail.go?type=gene&acc=65010,,,65010.0,SLC26A6,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SLC26A6 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
200,328537,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SLC2A1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
201,328538,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,339665,SLC35E4,https://ctdbase.org/detail.go?type=gene&acc=339665,,,339665.0,SLC35E4,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SLC35E4 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
202,328539,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,80255,SLC35F5,https://ctdbase.org/detail.go?type=gene&acc=80255,,,80255.0,SLC35F5,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SLC35F5 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
203,328540,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,80723,SLC35G2,https://ctdbase.org/detail.go?type=gene&acc=80723,,,80723.0,SLC35G2,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SLC35G2 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
204,328541,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,120103,SLC36A4,https://ctdbase.org/detail.go?type=gene&acc=120103,,,120103.0,SLC36A4,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SLC36A4 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
205,328542,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,84255,SLC37A3,https://ctdbase.org/detail.go?type=gene&acc=84255,,,84255.0,SLC37A3,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SLC37A3 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
206,330132,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,65124,SOWAHC,https://ctdbase.org/detail.go?type=gene&acc=65124,,,65124.0,SOWAHC,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SOWAHC mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
207,330133,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,9580,SOX13,https://ctdbase.org/detail.go?type=gene&acc=9580,,,9580.0,SOX13,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SOX13 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
208,330134,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,9576,SPAG6,https://ctdbase.org/detail.go?type=gene&acc=9576,,,9576.0,SPAG6,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SPAG6 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
209,330135,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SPARC mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
210,330136,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,8404,SPARCL1,https://ctdbase.org/detail.go?type=gene&acc=8404,,,8404.0,SPARCL1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of SPARCL1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
211,330137,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,221178,SPATA13,https://ctdbase.org/detail.go?type=gene&acc=221178,,,221178.0,SPATA13,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SPATA13 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
212,330138,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,84690,SPATA22,https://ctdbase.org/detail.go?type=gene&acc=84690,,,84690.0,SPATA22,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SPATA22 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
213,330139,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,6689,SPIB,https://ctdbase.org/detail.go?type=gene&acc=6689,,,6689.0,SPIB,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of SPIB mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
214,323505,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,9980,DOP1B,https://ctdbase.org/detail.go?type=gene&acc=9980,,,9980.0,DOP1B,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of DOP1B mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
215,323506,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,84444,DOT1L,https://ctdbase.org/detail.go?type=gene&acc=84444,,,84444.0,DOT1L,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate affects the expression of DOT1L mRNA,,,PMID:30934153,https://www.ncbi.nlm.nih.gov/pubmed/30934153,30934153,,
216,323507,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,84444,DOT1L,https://ctdbase.org/detail.go?type=gene&acc=84444,,,84444.0,DOT1L,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of DOT1L mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
217,323508,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,25911,DPCD,https://ctdbase.org/detail.go?type=gene&acc=25911,,,25911.0,DPCD,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of DPCD mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
218,325812,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,440275,EIF2AK4,https://ctdbase.org/detail.go?type=gene&acc=440275,,,440275.0,EIF2AK4,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of EIF2AK4 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
219,325813,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,1967,EIF2B1,https://ctdbase.org/detail.go?type=gene&acc=1967,,,1967.0,EIF2B1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of EIF2B1 mRNA,,,PMID:17361019,https://www.ncbi.nlm.nih.gov/pubmed/17361019,17361019,,
220,325814,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,8890,EIF2B4,https://ctdbase.org/detail.go?type=gene&acc=8890,,,8890.0,EIF2B4,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of EIF2B4 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
221,325815,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,8890,EIF2B4,https://ctdbase.org/detail.go?type=gene&acc=8890,,,8890.0,EIF2B4,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of EIF2B4 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
222,325816,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of EIF2S1 protein modified form|4-phenylbutyric acid inhibits the reaction [dibutyl phthalate results in increased expression of EIF2S1 protein modified form],,,PMID:26804720,https://www.ncbi.nlm.nih.gov/pubmed/26804720,26804720,,
223,326765,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,55740,ENAH,https://ctdbase.org/detail.go?type=gene&acc=55740,,,55740.0,ENAH,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of ENAH mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
224,326766,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,8507,ENC1,https://ctdbase.org/detail.go?type=gene&acc=8507,,,8507.0,ENC1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of ENC1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
225,327154,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,23136,EPB41L3,https://ctdbase.org/detail.go?type=gene&acc=23136,,,23136.0,EPB41L3,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of EPB41L3 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
226,327155,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,2038,EPB42,https://ctdbase.org/detail.go?type=gene&acc=2038,,,2038.0,EPB42,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of EPB42 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
227,327156,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,54749,EPDR1,https://ctdbase.org/detail.go?type=gene&acc=54749,,,54749.0,EPDR1,10116.0,Rattus norvegicus (Norway rat),[diethyl phthalate co-treated with diethylhexyl phthalate co-treated with dibutyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EPDR1 mRNA,,,PMID:31199487,https://www.ncbi.nlm.nih.gov/pubmed/31199487,31199487,,
228,329007,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,56915,EXOSC5,https://ctdbase.org/detail.go?type=gene&acc=56915,,,56915.0,EXOSC5,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of EXOSC5 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
229,329008,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,118460,EXOSC6,https://ctdbase.org/detail.go?type=gene&acc=118460,,,118460.0,EXOSC6,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of EXOSC6 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
230,329009,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,23016,EXOSC7,https://ctdbase.org/detail.go?type=gene&acc=23016,,,23016.0,EXOSC7,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of EXOSC7 mRNA,,,PMID:17361019,https://www.ncbi.nlm.nih.gov/pubmed/17361019,17361019,,
231,330796,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222.0,FDFT1,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of FDFT1 mRNA,,,PMID:17379624|PMID:21266533|PMID:21745491,https://www.ncbi.nlm.nih.gov/pubmed/17379624|https://www.ncbi.nlm.nih.gov/pubmed/21266533|https://www.ncbi.nlm.nih.gov/pubmed/21745491,17379624|21266533|21745491,,
232,330797,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,2224,FDPS,https://ctdbase.org/detail.go?type=gene&acc=2224,,,2224.0,FDPS,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of FDPS mRNA,,,PMID:17379624|PMID:21266533|PMID:21745491|PMID:33983380,https://www.ncbi.nlm.nih.gov/pubmed/17379624|https://www.ncbi.nlm.nih.gov/pubmed/21266533|https://www.ncbi.nlm.nih.gov/pubmed/21745491|https://www.ncbi.nlm.nih.gov/pubmed/33983380,17379624|21266533|21745491|33983380,,
233,330798,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,2230,FDX1,https://ctdbase.org/detail.go?type=gene&acc=2230,,,2230.0,FDX1,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of FDX1 mRNA,,,PMID:17379624|PMID:21266533|PMID:21745491,https://www.ncbi.nlm.nih.gov/pubmed/17379624|https://www.ncbi.nlm.nih.gov/pubmed/21266533|https://www.ncbi.nlm.nih.gov/pubmed/21745491,17379624|21266533|21745491,,
234,330799,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,2232,FDXR,https://ctdbase.org/detail.go?type=gene&acc=2232,,,2232.0,FDXR,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of FDXR mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
235,330800,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,2232,FDXR,https://ctdbase.org/detail.go?type=gene&acc=2232,,,2232.0,FDXR,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of FDXR mRNA,,,PMID:17379624|PMID:21266533|PMID:21745491,https://www.ncbi.nlm.nih.gov/pubmed/17379624|https://www.ncbi.nlm.nih.gov/pubmed/21266533|https://www.ncbi.nlm.nih.gov/pubmed/21745491,17379624|21266533|21745491,,
236,330801,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,2235,FECH,https://ctdbase.org/detail.go?type=gene&acc=2235,,,2235.0,FECH,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of FECH mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
237,330802,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,2237,FEN1,https://ctdbase.org/detail.go?type=gene&acc=2237,,,2237.0,FEN1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of FEN1 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
238,330989,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,83706,FERMT3,https://ctdbase.org/detail.go?type=gene&acc=83706,,,83706.0,FERMT3,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of FERMT3 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
239,330990,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,9638,FEZ1,https://ctdbase.org/detail.go?type=gene&acc=9638,,,9638.0,FEZ1,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of FEZ1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
240,330991,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,14194,FH1,https://ctdbase.org/detail.go?type=gene&acc=14194,,,14194.0,Fh1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of FH1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
241,330992,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,9638,FEZ1,https://ctdbase.org/detail.go?type=gene&acc=9638,,,9638.0,FEZ1,10116.0,Rattus norvegicus (Norway rat),[diethyl phthalate co-treated with diethylhexyl phthalate co-treated with dibutyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FEZ1 mRNA,,,PMID:31199487,https://www.ncbi.nlm.nih.gov/pubmed/31199487,31199487,,
242,326470,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,7106,TSPAN4,https://ctdbase.org/detail.go?type=gene&acc=7106,,,7106.0,TSPAN4,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of TSPAN4 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
243,326471,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,7103,TSPAN8,https://ctdbase.org/detail.go?type=gene&acc=7103,,,7103.0,TSPAN8,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of TSPAN8 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
244,322056,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,79074,C2ORF49,https://ctdbase.org/detail.go?type=gene&acc=79074,,,79074.0,C2orf49,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in decreased expression of C2ORF49 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
245,322057,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,79669,C3ORF52,https://ctdbase.org/detail.go?type=gene&acc=79669,,,79669.0,C3orf52,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in decreased expression of C3ORF52 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
246,323499,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,1303,COL12A1,https://ctdbase.org/detail.go?type=gene&acc=1303,,,1303.0,COL12A1,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in increased expression of COL12A1 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
247,323500,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,7955.0,Danio rerio (zebrafish),Disulfiram results in decreased expression of COL1A2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
248,323501,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in increased expression of COL1A2 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
249,323502,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,7955.0,Danio rerio (zebrafish),Disulfiram affects the expression of COL2A1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
250,323503,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in increased expression of COL3A1 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
251,323504,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,1282,COL4A1,https://ctdbase.org/detail.go?type=gene&acc=1282,,,1282.0,COL4A1,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in increased expression of COL4A1 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
252,324642,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,25879,DCAF13,https://ctdbase.org/detail.go?type=gene&acc=25879,,,25879.0,DCAF13,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in decreased expression of DCAF13 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
253,324643,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,407638,DCTN1A,https://ctdbase.org/detail.go?type=gene&acc=407638,,,407638.0,dctn1a,7955.0,Danio rerio (zebrafish),Disulfiram results in decreased expression of DCTN1A mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
254,324644,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,51181,DCXR,https://ctdbase.org/detail.go?type=gene&acc=51181,,,51181.0,DCXR,9606.0,Homo sapiens (human),[disulfiram co-treated with NADP] binds to DCXR protein,,,PMID:25526675,https://www.ncbi.nlm.nih.gov/pubmed/25526675,25526675,,
255,324645,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in decreased expression of DDIT3 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
256,324646,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,10212,DDX39A,https://ctdbase.org/detail.go?type=gene&acc=10212,,,10212.0,DDX39A,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in decreased expression of DDX39A mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
257,324647,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,1655,DDX5,https://ctdbase.org/detail.go?type=gene&acc=1655,,,1655.0,DDX5,7955.0,Danio rerio (zebrafish),Disulfiram results in decreased expression of DDX5 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
258,324648,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,55601,DDX60,https://ctdbase.org/detail.go?type=gene&acc=55601,,,55601.0,DDX60,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in increased expression of DDX60 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
259,324649,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,162989,DEDD2,https://ctdbase.org/detail.go?type=gene&acc=162989,,,162989.0,DEDD2,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in decreased expression of DEDD2 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
260,324650,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,55894,DEFB103B,https://ctdbase.org/detail.go?type=gene&acc=55894,,,55894.0,DEFB103B,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in decreased expression of DEFB103B mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
261,325957,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,447823,FTH1B,https://ctdbase.org/detail.go?type=gene&acc=447823,,,447823.0,fth1b,7955.0,Danio rerio (zebrafish),Disulfiram results in increased expression of FTH1B mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
262,325958,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,729009,FTH1P20,https://ctdbase.org/detail.go?type=gene&acc=729009,,,729009.0,FTH1P20,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in decreased expression of FTH1P20 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
263,329001,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,4015,LOX,https://ctdbase.org/detail.go?type=gene&acc=4015,,,4015.0,LOX,7955.0,Danio rerio (zebrafish),LOX results in decreased susceptibility to disulfiram,,,PMID:20045017,https://www.ncbi.nlm.nih.gov/pubmed/20045017,20045017,,
264,329002,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,4016,LOXL1,https://ctdbase.org/detail.go?type=gene&acc=4016,,,4016.0,LOXL1,7955.0,Danio rerio (zebrafish),LOXL1 results in decreased susceptibility to disulfiram,,,PMID:20045017,https://www.ncbi.nlm.nih.gov/pubmed/20045017,20045017,,
265,329003,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,100124531,LOXL5B,https://ctdbase.org/detail.go?type=gene&acc=100124531,,,100124531.0,loxl5b,7955.0,Danio rerio (zebrafish),LOXL5B results in decreased susceptibility to disulfiram,,,PMID:20045017,https://www.ncbi.nlm.nih.gov/pubmed/20045017,20045017,,
266,329004,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,157638,LRATD2,https://ctdbase.org/detail.go?type=gene&acc=157638,,,157638.0,LRATD2,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in increased expression of LRATD2 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
267,329005,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,7804,LRP8,https://ctdbase.org/detail.go?type=gene&acc=7804,,,7804.0,LRP8,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in increased expression of LRP8 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
268,329006,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,286006,LSMEM1,https://ctdbase.org/detail.go?type=gene&acc=286006,,,286006.0,LSMEM1,9606.0,Homo sapiens (human),[disulfiram binds to copper] which results in decreased expression of LSMEM1 mRNA,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,
269,321205,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of SERPINE2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
270,321206,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,9606.0,Homo sapiens (human),Valproic acid affects the expression of SERPINE2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
271,321207,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of SERPINE2 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
272,321208,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of SERPINE2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
273,321209,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of SERPINE2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
274,321210,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,647174,SERPINE3,https://ctdbase.org/detail.go?type=gene&acc=647174,,,647174.0,SERPINE3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of SERPINE3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
275,321524,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79144,PPDPF,https://ctdbase.org/detail.go?type=gene&acc=79144,,,79144.0,PPDPF,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PPDPF mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
276,321525,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,338304,PPDPFA,https://ctdbase.org/detail.go?type=gene&acc=338304,,,338304.0,ppdpfa,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of PPDPFA mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
277,321698,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,871,SERPINH1,https://ctdbase.org/detail.go?type=gene&acc=871,,,871.0,SERPINH1,9606.0,Homo sapiens (human),Valproic acid affects the expression of SERPINH1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
278,321699,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,871,SERPINH1,https://ctdbase.org/detail.go?type=gene&acc=871,,,871.0,SERPINH1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of SERPINH1 mRNA,,,PMID:23179753|PMID:25192806|PMID:26272509|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|25192806|26272509|28001369|29154799,,
279,321700,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,871,SERPINH1,https://ctdbase.org/detail.go?type=gene&acc=871,,,871.0,SERPINH1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of SERPINH1 mRNA,,,PMID:17292431|PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17292431|https://www.ncbi.nlm.nih.gov/pubmed/17963808,17292431|17963808,,
280,321701,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5274,SERPINI1,https://ctdbase.org/detail.go?type=gene&acc=5274,,,5274.0,SERPINI1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINI1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
281,321702,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5274,SERPINI1,https://ctdbase.org/detail.go?type=gene&acc=5274,,,5274.0,SERPINI1,9606.0,Homo sapiens (human),Valproic acid affects the expression of SERPINI1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
282,322693,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5494,PPM1A,https://ctdbase.org/detail.go?type=gene&acc=5494,,,5494.0,PPM1A,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPM1A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
283,322694,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5494,PPM1A,https://ctdbase.org/detail.go?type=gene&acc=5494,,,5494.0,PPM1A,9606.0,Homo sapiens (human),Valproic acid affects the expression of PPM1A mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
284,322695,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5494,PPM1A,https://ctdbase.org/detail.go?type=gene&acc=5494,,,5494.0,PPM1A,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PPM1A mRNA,,,PMID:23179753|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|24935251|25192806|26272509|27188386,,
285,322696,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5494,PPM1A,https://ctdbase.org/detail.go?type=gene&acc=5494,,,5494.0,PPM1A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PPM1A mRNA,,,PMID:19101580,https://www.ncbi.nlm.nih.gov/pubmed/19101580,19101580,,
286,322840,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79918,SETD6,https://ctdbase.org/detail.go?type=gene&acc=79918,,,79918.0,SETD6,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of SETD6 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
287,322841,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80854,SETD7,https://ctdbase.org/detail.go?type=gene&acc=80854,,,80854.0,SETD7,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of SETD7 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
288,322842,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80854,SETD7,https://ctdbase.org/detail.go?type=gene&acc=80854,,,80854.0,SETD7,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SETD7 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
289,322843,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80854,SETD7,https://ctdbase.org/detail.go?type=gene&acc=80854,,,80854.0,SETD7,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of SETD7 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
290,322844,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80854,SETD7,https://ctdbase.org/detail.go?type=gene&acc=80854,,,80854.0,SETD7,9606.0,Homo sapiens (human),Valproic acid results in increased expression of SETD7 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24935251|26272509,,
291,322845,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80854,SETD7,https://ctdbase.org/detail.go?type=gene&acc=80854,,,80854.0,SETD7,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of SETD7 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
292,323825,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4659,PPP1R12A,https://ctdbase.org/detail.go?type=gene&acc=4659,,,4659.0,PPP1R12A,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of PPP1R12A mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
293,323826,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4660,PPP1R12B,https://ctdbase.org/detail.go?type=gene&acc=4660,,,4660.0,PPP1R12B,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PPP1R12B mRNA,,,PMID:37505509,https://www.ncbi.nlm.nih.gov/pubmed/37505509,37505509,,
294,323827,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4660,PPP1R12B,https://ctdbase.org/detail.go?type=gene&acc=4660,,,4660.0,PPP1R12B,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of PPP1R12B mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
295,323828,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54776,PPP1R12C,https://ctdbase.org/detail.go?type=gene&acc=54776,,,54776.0,PPP1R12C,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PPP1R12C mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
296,323829,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54776,PPP1R12C,https://ctdbase.org/detail.go?type=gene&acc=54776,,,54776.0,PPP1R12C,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PPP1R12C mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
297,323830,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23368,PPP1R13B,https://ctdbase.org/detail.go?type=gene&acc=23368,,,23368.0,PPP1R13B,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PPP1R13B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
298,323831,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23368,PPP1R13B,https://ctdbase.org/detail.go?type=gene&acc=23368,,,23368.0,PPP1R13B,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of PPP1R13B mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
299,324314,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23645,PPP1R15A,https://ctdbase.org/detail.go?type=gene&acc=23645,,,23645.0,PPP1R15A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PPP1R15A mrna|valproic acid results in increased methylation of PPP1R15A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
300,324315,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23645,PPP1R15A,https://ctdbase.org/detail.go?type=gene&acc=23645,,,23645.0,PPP1R15A,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of PPP1R15A mRNA,,,PMID:21318169,https://www.ncbi.nlm.nih.gov/pubmed/21318169,21318169,,
301,324316,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84919,PPP1R15B,https://ctdbase.org/detail.go?type=gene&acc=84919,,,84919.0,PPP1R15B,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of PPP1R15B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
302,324317,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84919,PPP1R15B,https://ctdbase.org/detail.go?type=gene&acc=84919,,,84919.0,PPP1R15B,9606.0,Homo sapiens (human),Valproic acid affects the expression of PPP1R15B mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
303,324318,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84919,PPP1R15B,https://ctdbase.org/detail.go?type=gene&acc=84919,,,84919.0,PPP1R15B,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PPP1R15B mrna|valproic acid results in decreased methylation of PPP1R15B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
304,324319,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84988,PPP1R16A,https://ctdbase.org/detail.go?type=gene&acc=84988,,,84988.0,PPP1R16A,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PPP1R16A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
305,325672,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5511,PPP1R8,https://ctdbase.org/detail.go?type=gene&acc=5511,,,5511.0,PPP1R8,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of PPP1R8 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
306,325673,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55607,PPP1R9A,https://ctdbase.org/detail.go?type=gene&acc=55607,,,55607.0,PPP1R9A,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of PPP1R9A mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
307,325674,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55607,PPP1R9A,https://ctdbase.org/detail.go?type=gene&acc=55607,,,55607.0,PPP1R9A,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R9A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
308,325675,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55607,PPP1R9A,https://ctdbase.org/detail.go?type=gene&acc=55607,,,55607.0,PPP1R9A,9606.0,Homo sapiens (human),Valproic acid affects the expression of PPP1R9A mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
309,325817,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2641,GCG,https://ctdbase.org/detail.go?type=gene&acc=2641,,,2641.0,GCG,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of GCG gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
310,325818,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2642,GCGR,https://ctdbase.org/detail.go?type=gene&acc=2642,,,2642.0,GCGR,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of GCGR gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
311,325819,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2643,GCH1,https://ctdbase.org/detail.go?type=gene&acc=2643,,,2643.0,GCH1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCH1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
312,325820,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2643,GCH1,https://ctdbase.org/detail.go?type=gene&acc=2643,,,2643.0,GCH1,9606.0,Homo sapiens (human),Valproic acid affects the expression of GCH1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
313,325821,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2643,GCH1,https://ctdbase.org/detail.go?type=gene&acc=2643,,,2643.0,GCH1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of GCH1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24383497|24935251|25192806|26272509|27188386|28001369|29154799,,
314,326315,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5526,PPP2R5B,https://ctdbase.org/detail.go?type=gene&acc=5526,,,5526.0,PPP2R5B,9606.0,Homo sapiens (human),Valproic acid affects the expression of PPP2R5B mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
315,326316,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5526,PPP2R5B,https://ctdbase.org/detail.go?type=gene&acc=5526,,,5526.0,PPP2R5B,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PPP2R5B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
316,326317,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5527,PPP2R5C,https://ctdbase.org/detail.go?type=gene&acc=5527,,,5527.0,PPP2R5C,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PPP2R5C mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
317,326318,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5527,PPP2R5C,https://ctdbase.org/detail.go?type=gene&acc=5527,,,5527.0,PPP2R5C,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PPP2R5C gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
318,326319,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5529,PPP2R5E,https://ctdbase.org/detail.go?type=gene&acc=5529,,,5529.0,PPP2R5E,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
319,326320,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5529,PPP2R5E,https://ctdbase.org/detail.go?type=gene&acc=5529,,,5529.0,PPP2R5E,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PPP2R5E mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|26272509|28001369,,
320,326321,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5529,PPP2R5E,https://ctdbase.org/detail.go?type=gene&acc=5529,,,5529.0,PPP2R5E,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of PPP2R5E mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
321,326464,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10019,SH2B3,https://ctdbase.org/detail.go?type=gene&acc=10019,,,10019.0,SH2B3,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH2B3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
322,326465,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10019,SH2B3,https://ctdbase.org/detail.go?type=gene&acc=10019,,,10019.0,SH2B3,9606.0,Homo sapiens (human),Valproic acid affects the expression of SH2B3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
323,326466,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10019,SH2B3,https://ctdbase.org/detail.go?type=gene&acc=10019,,,10019.0,SH2B3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of SH2B3 mRNA,,,PMID:19101580|PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,19101580|23179753|24935251|26272509|28001369,,
324,326467,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10019,SH2B3,https://ctdbase.org/detail.go?type=gene&acc=10019,,,10019.0,SH2B3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of SH2B3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
325,326468,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10019,SH2B3,https://ctdbase.org/detail.go?type=gene&acc=10019,,,10019.0,SH2B3,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of SH2B3 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
326,326469,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4068,SH2D1A,https://ctdbase.org/detail.go?type=gene&acc=4068,,,4068.0,SH2D1A,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of SH2D1A mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
327,327298,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8487,GEMIN2,https://ctdbase.org/detail.go?type=gene&acc=8487,,,8487.0,GEMIN2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of GEMIN2 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
328,327299,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,50628,GEMIN4,https://ctdbase.org/detail.go?type=gene&acc=50628,,,50628.0,GEMIN4,9606.0,Homo sapiens (human),Valproic acid affects the expression of GEMIN4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
329,327300,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,50628,GEMIN4,https://ctdbase.org/detail.go?type=gene&acc=50628,,,50628.0,GEMIN4,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of GEMIN4 mRNA,,,PMID:22083351|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/22083351|https://www.ncbi.nlm.nih.gov/pubmed/29154799,22083351|29154799,,
330,328027,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,81577,GFOD2,https://ctdbase.org/detail.go?type=gene&acc=81577,,,81577.0,GFOD2,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of GFOD2 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
331,328206,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26751,SH3YL1,https://ctdbase.org/detail.go?type=gene&acc=26751,,,26751.0,SH3YL1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of SH3YL1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
332,328207,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,50944,SHANK1,https://ctdbase.org/detail.go?type=gene&acc=50944,,,50944.0,SHANK1,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of SHANK1 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
333,328208,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22941,SHANK2,https://ctdbase.org/detail.go?type=gene&acc=22941,,,22941.0,SHANK2,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of SHANK2 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
334,328209,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22941,SHANK2,https://ctdbase.org/detail.go?type=gene&acc=22941,,,22941.0,SHANK2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SHANK2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
335,328210,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22941,SHANK2,https://ctdbase.org/detail.go?type=gene&acc=22941,,,22941.0,SHANK2,9606.0,Homo sapiens (human),Valproic acid affects the expression of SHANK2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
336,328211,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,92799,SHKBP1,https://ctdbase.org/detail.go?type=gene&acc=92799,,,92799.0,SHKBP1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of SHKBP1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
337,328212,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22941,SHANK2,https://ctdbase.org/detail.go?type=gene&acc=22941,,,22941.0,SHANK2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of SHANK2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|24935251|26272509,,
338,328350,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56980,PRDM10,https://ctdbase.org/detail.go?type=gene&acc=56980,,,56980.0,PRDM10,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PRDM10 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
339,328351,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,440072,PRDM10-DT,https://ctdbase.org/detail.go?type=gene&acc=440072,,,440072.0,PRDM10-DT,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of PRDM10-DT gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
340,328352,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56981,PRDM11,https://ctdbase.org/detail.go?type=gene&acc=56981,,,56981.0,PRDM11,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PRDM11 mRNA,,,PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,26272509|28001369,,
341,328353,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56981,PRDM11,https://ctdbase.org/detail.go?type=gene&acc=56981,,,56981.0,PRDM11,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PRDM11 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
342,328354,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56981,PRDM11,https://ctdbase.org/detail.go?type=gene&acc=56981,,,56981.0,PRDM11,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of PRDM11 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
343,328355,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,59335,PRDM12,https://ctdbase.org/detail.go?type=gene&acc=59335,,,59335.0,PRDM12,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PRDM12 mrna|valproic acid results in increased methylation of PRDM12 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
344,328356,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,59335,PRDM12,https://ctdbase.org/detail.go?type=gene&acc=59335,,,59335.0,PRDM12,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of PRDM12 mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
345,328357,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,59336,PRDM13,https://ctdbase.org/detail.go?type=gene&acc=59336,,,59336.0,PRDM13,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PRDM13 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
346,328358,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,63978,PRDM14,https://ctdbase.org/detail.go?type=gene&acc=63978,,,63978.0,PRDM14,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PRDM14 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
347,328842,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11107,PRDM5,https://ctdbase.org/detail.go?type=gene&acc=11107,,,11107.0,PRDM5,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PRDM5 mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
348,328843,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11107,PRDM5,https://ctdbase.org/detail.go?type=gene&acc=11107,,,11107.0,PRDM5,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of PRDM5 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
349,328844,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,93166,PRDM6,https://ctdbase.org/detail.go?type=gene&acc=93166,,,93166.0,PRDM6,9606.0,Homo sapiens (human),Valproic acid affects the expression of PRDM6 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
350,328845,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,93166,PRDM6,https://ctdbase.org/detail.go?type=gene&acc=93166,,,93166.0,PRDM6,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PRDM6 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
351,328846,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,93166,PRDM6,https://ctdbase.org/detail.go?type=gene&acc=93166,,,93166.0,PRDM6,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PRDM6 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
352,328847,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56978,PRDM8,https://ctdbase.org/detail.go?type=gene&acc=56978,,,56978.0,PRDM8,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of PRDM8 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
353,328848,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56978,PRDM8,https://ctdbase.org/detail.go?type=gene&acc=56978,,,56978.0,PRDM8,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of PRDM8 mRNA,,,PMID:29261810,https://www.ncbi.nlm.nih.gov/pubmed/29261810,29261810,,
354,328849,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56978,PRDM8,https://ctdbase.org/detail.go?type=gene&acc=56978,,,56978.0,PRDM8,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of PRDM8 mRNA,,,PMID:34779009,https://www.ncbi.nlm.nih.gov/pubmed/34779009,34779009,,
355,328850,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of PRDX1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
356,329209,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1038,CDR1,https://ctdbase.org/detail.go?type=gene&acc=1038,,,1038.0,CDR1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CDR1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
357,329210,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1039,CDR2,https://ctdbase.org/detail.go?type=gene&acc=1039,,,1039.0,CDR2,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of CDR2 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
358,329644,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9837,GINS1,https://ctdbase.org/detail.go?type=gene&acc=9837,,,9837.0,GINS1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of GINS1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
359,329645,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51659,GINS2,https://ctdbase.org/detail.go?type=gene&acc=51659,,,51659.0,GINS2,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of GINS2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
360,329646,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51659,GINS2,https://ctdbase.org/detail.go?type=gene&acc=51659,,,51659.0,GINS2,9606.0,Homo sapiens (human),Valproic acid affects the expression of GINS2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
361,329825,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,9606.0,Homo sapiens (human),Valproic acid inhibits the reaction [colforsin results in decreased expression of GJA1 mrna],,,PMID:37385477,https://www.ncbi.nlm.nih.gov/pubmed/37385477,37385477,,
362,329826,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of GJA1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
363,329827,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,10090.0,Mus musculus (house mouse),Valproic acid analog results in decreased expression of GJA1 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
364,329828,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of GJA1 mRNA,,,PMID:20546886|PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/20546886|https://www.ncbi.nlm.nih.gov/pubmed/21427059,20546886|21427059,,
365,329829,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,30236,GJA1B,https://ctdbase.org/detail.go?type=gene&acc=30236,,,30236.0,gja1b,7955.0,Danio rerio (zebrafish),Valproic acid results in decreased expression of GJA1B mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
366,329978,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2701,GJA4,https://ctdbase.org/detail.go?type=gene&acc=2701,,,2701.0,GJA4,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of GJA4 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
367,329979,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,404625,GJA9B,https://ctdbase.org/detail.go?type=gene&acc=404625,,,404625.0,gja9b,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of GJA9B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
368,330301,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CEBPB mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|26272509|28001369,,
369,330302,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CEBPB gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
370,330303,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased methylation of CEBPB promoter|valproic acid results in decreased expression of CEBPB mRNA,,,PMID:33150595,https://www.ncbi.nlm.nih.gov/pubmed/33150595,33150595,,
371,330304,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,134549,SHROOM1,https://ctdbase.org/detail.go?type=gene&acc=134549,,,134549.0,SHROOM1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of SHROOM1 mrna|valproic acid results in increased methylation of SHROOM1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
372,330305,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,134549,SHROOM1,https://ctdbase.org/detail.go?type=gene&acc=134549,,,134549.0,SHROOM1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of SHROOM1 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
373,330306,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,134549,SHROOM1,https://ctdbase.org/detail.go?type=gene&acc=134549,,,134549.0,SHROOM1,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of SHROOM1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
374,330307,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,357,SHROOM2,https://ctdbase.org/detail.go?type=gene&acc=357,,,357.0,SHROOM2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of SHROOM2 mRNA,,,PMID:19101580,https://www.ncbi.nlm.nih.gov/pubmed/19101580,19101580,,
375,330308,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,357,SHROOM2,https://ctdbase.org/detail.go?type=gene&acc=357,,,357.0,SHROOM2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of SHROOM2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
376,330309,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57619,SHROOM3,https://ctdbase.org/detail.go?type=gene&acc=57619,,,57619.0,SHROOM3,9606.0,Homo sapiens (human),Valproic acid affects the expression of SHROOM3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
377,330310,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57619,SHROOM3,https://ctdbase.org/detail.go?type=gene&acc=57619,,,57619.0,SHROOM3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of SHROOM3 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
378,322527,3122,Therapeutic Target Database (TTD),2-Amino-7-phosphonoheptanoic acid,D0OZ2F,AP-7,https://idrblab.net/ttd/data/drug/details/D0OZ2F,T22285,Glutamate receptor ionotropic NMDA 2A (NMDAR2A),https://idrblab.net/ttd/data/target/details/T22285,Q12879,"Glutamate receptor ionotropic, NMDA 2A",2903.0,GRIN2A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
379,322528,3132,BindingDB,Thiorphan,21641,2-(2-benzyl-3-sulfanylpropanamido)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21641,5019,Neprilysin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5019,P07861,Neprilysin,24590.0,Mme,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),18,PMID:9247857|DOI:10.3109/14756369709035816,https://www.ncbi.nlm.nih.gov/pubmed/9247857|https://doi.org/10.3109/14756369709035816,9247857,10.3109/14756369709035816,
380,322529,3152,BindingDB,Donepezil,8960,"(+/-)-2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-indan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=8960,3621,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3621,O42275,Acetylcholinesterase,,,8005.0,Electrophorus electricus (electric eel),,IC50 (nM),23,PMID:28267984|DOI:10.1016/j.bioorg.2017.02.016,https://www.ncbi.nlm.nih.gov/pubmed/28267984|https://doi.org/10.1016/j.bioorg.2017.02.016,28267984,10.1016/j.bioorg.2017.02.016,
381,322530,3152,BindingDB,Donepezil,8960,"(+/-)-2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-indan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=8960,1044,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1044,,,,,,,,IC50 (nM),21400,PMID:28267984|DOI:10.1016/j.bioorg.2017.02.016,https://www.ncbi.nlm.nih.gov/pubmed/28267984|https://doi.org/10.1016/j.bioorg.2017.02.016,28267984,10.1016/j.bioorg.2017.02.016,
382,321051,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,51114,ZDHHC9,https://ctdbase.org/detail.go?type=gene&acc=51114,,,51114.0,ZDHHC9,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of ZDHHC9 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
383,321052,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,9839,ZEB2,https://ctdbase.org/detail.go?type=gene&acc=9839,,,9839.0,ZEB2,9606.0,Homo sapiens (human),Endosulfan results in increased expression of ZEB2 protein|ly2109761 inhibits the reaction [endosulfan results in increased expression of ZEB2 protein],,,PMID:32413665,https://www.ncbi.nlm.nih.gov/pubmed/32413665,32413665,,
384,321053,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,90637,ZFAND2A,https://ctdbase.org/detail.go?type=gene&acc=90637,,,90637.0,ZFAND2A,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of ZFAND2A mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
385,323651,3278,Comparative Toxicogenomics Database (CTD),Ethacrynic acid,D004976,Ethacrynic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004976,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176.0,LEF1,9606.0,Homo sapiens (human),Ethacrynic acid results in decreased expression of LEF1 mrna|ethacrynic acid binds to LEF1 protein,,,PMID:20011538,https://www.ncbi.nlm.nih.gov/pubmed/20011538,20011538,,
386,323652,3278,Comparative Toxicogenomics Database (CTD),Ethacrynic acid,D004976,Ethacrynic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004976,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,9606.0,Homo sapiens (human),Ethacrynic acid results in increased expression of MAP2K1 protein,,,PMID:14556662,https://www.ncbi.nlm.nih.gov/pubmed/14556662,14556662,,
387,323653,3278,Comparative Toxicogenomics Database (CTD),Ethacrynic acid,D004976,Ethacrynic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004976,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606.0,Homo sapiens (human),Ethacrynic acid results in decreased expression of MAPK14 protein,,,PMID:14556662,https://www.ncbi.nlm.nih.gov/pubmed/14556662,14556662,,
388,323654,3278,Comparative Toxicogenomics Database (CTD),Ethacrynic acid,D004976,Ethacrynic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004976,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Ethacrynic acid results in increased expression of MAPK3 protein,,,PMID:14556662,https://www.ncbi.nlm.nih.gov/pubmed/14556662,14556662,,
389,323655,3278,Comparative Toxicogenomics Database (CTD),Ethacrynic acid,D004976,Ethacrynic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004976,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),Ethacrynic acid results in decreased expression of MAPK8 protein,,,PMID:14556662,https://www.ncbi.nlm.nih.gov/pubmed/14556662,14556662,,
390,323656,3278,Comparative Toxicogenomics Database (CTD),Ethacrynic acid,D004976,Ethacrynic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004976,4170,MCL1,https://ctdbase.org/detail.go?type=gene&acc=4170,,,4170.0,MCL1,9606.0,Homo sapiens (human),Ethacrynic acid results in decreased expression of MCL1 protein|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [arsenic trioxide promotes the reaction [ethacrynic acid results in decreased expression of MCL1 protein]]|mcl1 mutant form promotes the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein]|arsenic trioxide promotes the reaction [ethacrynic acid results in decreased expression of MCL1 protein]|mcl1 mutant form results in increased susceptibility to [ethacrynic acid co-treated with arsenic trioxide]|acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [ethacrynic acid results in decreased expression of MCL1 protein]]|mcl1 mutant form promotes the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of CASP9 protein]|[mcl1 mutant form results in increased susceptibility to [ethacrynic acid co-treated with arsenic trioxide]] which results in increased cleavage of CASP3 protein|cat mutant form promotes the reaction [arsenic trioxide promotes the reaction [ethacrynic acid results in decreased expression of MCL1 protein]]|pyrazolanthrone inhibits the reaction [arsenic trioxide promotes the reaction [ethacrynic acid results in decreased expression of MCL1 protein]],,,PMID:23082001,https://www.ncbi.nlm.nih.gov/pubmed/23082001,23082001,,
391,324140,3278,Comparative Toxicogenomics Database (CTD),Ethacrynic acid,D004976,Ethacrynic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004976,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to ethacrynic acid]|abcc1 protein results in decreased susceptibility to ethacrynic acid,,,PMID:10900222,https://www.ncbi.nlm.nih.gov/pubmed/10900222,10900222,,
392,327456,3331,Drug Gene Interaction database (DGIdb),Felbamate,,FELBAMATE,https://www.dgidb.org/drugs/rxcui:24812,,CYP1A2,https://www.dgidb.org/genes/hgnc:2596,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
393,323970,3333,Drug Gene Interaction database (DGIdb),Felodipine,,FELODIPINE,https://www.dgidb.org/drugs/rxcui:4316,,ABCG2,https://www.dgidb.org/genes/hgnc:74,,,9429.0,ABCG2,9606.0,Homo sapiens (human),,,,,,,,
394,327457,3333,Drug Gene Interaction database (DGIdb),Felodipine,,FELODIPINE,https://www.dgidb.org/drugs/rxcui:4316,,MAPT,https://www.dgidb.org/genes/hgnc:6893,,,4137.0,MAPT,9606.0,Homo sapiens (human),,,,,,,,
395,323971,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9823.0,Sus scrofa (pig),Fenbendazole affects the expression of ABCB1 mRNA,,,PMID:26366864,https://www.ncbi.nlm.nih.gov/pubmed/26366864,26366864,,
396,323972,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,369,ARAF,https://ctdbase.org/detail.go?type=gene&acc=369,,,369.0,ARAF,9606.0,Homo sapiens (human),Fenbendazole analog results in decreased expression of ARAF protein,,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
397,323973,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,9212,AURKB,https://ctdbase.org/detail.go?type=gene&acc=9212,,,9212.0,AURKB,10116.0,Rattus norvegicus (Norway rat),Fenbendazole results in increased expression of AURKB protein,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
398,323974,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [fenbendazole results in increased expression of BAX protein]|fenbendazole analog results in increased expression of BAX protein|acetylcysteine inhibits the reaction [fenbendazole analog results in increased expression of BAX protein]|sb 203580 inhibits the reaction [fenbendazole results in increased expression of BAX protein]|fenbendazole results in increased expression of BAX protein|sb 203580 inhibits the reaction [fenbendazole analog results in increased expression of BAX protein],,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
399,323975,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Fenbendazole analog results in decreased expression of BCL2 protein|fenbendazole results in decreased expression of BCL2 protein,,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
400,323976,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Fenbendazole analog results in increased expression of CASP3 mrna|fenbendazole results in increased cleavage of CASP3 protein|fenbendazole analog results in increased cleavage of CASP3 protein,,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
401,323977,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),Fenbendazole analog results in increased expression of CASP8 mrna|fenbendazole results in increased expression of CASP8 mRNA,,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
402,323978,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Fenbendazole analog results in increased cleavage of CASP9 protein|fenbendazole results in increased expression of CASP9 mrna|fenbendazole results in increased cleavage of CASP9 protein|fenbendazole analog results in increased expression of CASP9 mRNA,,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
403,324484,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),Fenbendazole results in increased expression of H2AX protein|fenbendazole analog results in increased expression of H2AX protein,,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
404,324485,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,3297,HSF1,https://ctdbase.org/detail.go?type=gene&acc=3297,,,3297.0,HSF1,9606.0,Homo sapiens (human),Fenbendazole results in increased activity of HSF1 protein,,,PMID:34170685,https://www.ncbi.nlm.nih.gov/pubmed/34170685,34170685,,
405,324486,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606.0,Homo sapiens (human),Fenbendazole analog results in increased expression of IFNG mrna|fenbendazole results in increased expression of IFNG mRNA,,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
406,324487,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Fenbendazole analog results in increased expression of IL6 mrna|fenbendazole results in increased expression of IL6 mRNA,,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
407,324488,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,3570,IL6R,https://ctdbase.org/detail.go?type=gene&acc=3570,,,3570.0,IL6R,9606.0,Homo sapiens (human),Fenbendazole results in increased expression of IL6R protein modified form,,,PMID:20116850,https://www.ncbi.nlm.nih.gov/pubmed/20116850,20116850,,
408,324489,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,3619,INCENP,https://ctdbase.org/detail.go?type=gene&acc=3619,,,3619.0,INCENP,10116.0,Rattus norvegicus (Norway rat),Fenbendazole results in increased expression of INCENP protein,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
409,324490,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,9606.0,Homo sapiens (human),Fenbendazole results in decreased expression of MAPT protein,,,PMID:16930453,https://www.ncbi.nlm.nih.gov/pubmed/16930453,16930453,,
410,324491,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,4191,MDH2,https://ctdbase.org/detail.go?type=gene&acc=4191,,,4191.0,MDH2,9606.0,Homo sapiens (human),Fenbendazole analog results in increased expression of MDH2 mrna|fenbendazole results in increased expression of MDH2 mRNA,,,PMID:35569513,https://www.ncbi.nlm.nih.gov/pubmed/35569513,35569513,,
411,324492,3334,Comparative Toxicogenomics Database (CTD),Fenbendazole,D005273,Fenbendazole,https://ctdbase.org/detail.go?type=chem&acc=D005273,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,10116.0,Rattus norvegicus (Norway rat),Fenbendazole results in increased expression of MDM2 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
412,325959,3337,Comparative Toxicogenomics Database (CTD),Fenfluramine,D005277,Fenfluramine,https://ctdbase.org/detail.go?type=chem&acc=D005277,10879,SMR3B,https://ctdbase.org/detail.go?type=gene&acc=10879,,,10879.0,SMR3B,9606.0,Homo sapiens (human),Fenfluramine results in increased expression of SMR3B mRNA,,,PMID:22140631,https://www.ncbi.nlm.nih.gov/pubmed/22140631,22140631,,
413,325960,3337,Comparative Toxicogenomics Database (CTD),Fenfluramine,D005277,Fenfluramine,https://ctdbase.org/detail.go?type=chem&acc=D005277,89882,TPD52L3,https://ctdbase.org/detail.go?type=gene&acc=89882,,,89882.0,TPD52L3,9606.0,Homo sapiens (human),Fenfluramine results in increased expression of TPD52L3 mRNA,,,PMID:22140631,https://www.ncbi.nlm.nih.gov/pubmed/22140631,22140631,,
414,325961,3337,Comparative Toxicogenomics Database (CTD),Fenfluramine,D005277,Fenfluramine,https://ctdbase.org/detail.go?type=chem&acc=D005277,7481,WNT11,https://ctdbase.org/detail.go?type=gene&acc=7481,,,7481.0,WNT11,9606.0,Homo sapiens (human),Fenfluramine results in decreased expression of WNT11 mRNA,,,PMID:22140631,https://www.ncbi.nlm.nih.gov/pubmed/22140631,22140631,,
415,325962,3337,Comparative Toxicogenomics Database (CTD),Fenfluramine,D005277,Fenfluramine,https://ctdbase.org/detail.go?type=chem&acc=D005277,158866,ZDHHC15,https://ctdbase.org/detail.go?type=gene&acc=158866,,,158866.0,ZDHHC15,9606.0,Homo sapiens (human),Fenfluramine results in increased expression of ZDHHC15 mRNA,,,PMID:22140631,https://www.ncbi.nlm.nih.gov/pubmed/22140631,22140631,,
416,325963,3337,Comparative Toxicogenomics Database (CTD),Fenfluramine,D005277,Fenfluramine,https://ctdbase.org/detail.go?type=chem&acc=D005277,9765,ZFYVE16,https://ctdbase.org/detail.go?type=gene&acc=9765,,,9765.0,ZFYVE16,9606.0,Homo sapiens (human),Fenfluramine results in increased expression of ZFYVE16 mRNA,,,PMID:22140631,https://www.ncbi.nlm.nih.gov/pubmed/22140631,22140631,,
417,325964,3337,Comparative Toxicogenomics Database (CTD),Fenfluramine,D005277,Fenfluramine,https://ctdbase.org/detail.go?type=chem&acc=D005277,201516,ZSCAN4,https://ctdbase.org/detail.go?type=gene&acc=201516,,,201516.0,ZSCAN4,9606.0,Homo sapiens (human),Fenfluramine results in increased expression of ZSCAN4 mRNA,,,PMID:22140631,https://www.ncbi.nlm.nih.gov/pubmed/22140631,22140631,,
418,324787,3339,DrugBank,Fenofibrate,DB01039,Fenofibrate,https://www.drugbank.ca/drugs/DB01039,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15601807|PMID:26721703|PMID:27720395,https://www.ncbi.nlm.nih.gov/pubmed/15601807|https://www.ncbi.nlm.nih.gov/pubmed/26721703|https://www.ncbi.nlm.nih.gov/pubmed/27720395,15601807|26721703|27720395,,
419,324788,3339,DrugBank,Fenofibrate,DB01039,Fenofibrate,https://www.drugbank.ca/drugs/DB01039,BE0003536,Cytochrome P450 2C19,https://www.drugbank.ca/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
420,324789,3339,DrugBank,Fenofibrate,DB01039,Fenofibrate,https://www.drugbank.ca/drugs/DB01039,BE0003336,Cytochrome P450 2A6,https://www.drugbank.ca/bio_entities/BE0003336,P11509,Cytochrome P450 2A6,1548.0,CYP2A6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
421,324790,3339,DrugBank,Fenofibrate,DB01039,Fenofibrate,https://www.drugbank.ca/drugs/DB01039,BE0000126,Aldo-keto reductase family 1 member C1,https://www.drugbank.ca/bio_entities/BE0000126,Q04828,Aldo-keto reductase family 1 member C1,1645.0,AKR1C1,9606.0,Homo sapiens (human),Substrate,,,PMID:27599626,https://www.ncbi.nlm.nih.gov/pubmed/27599626,27599626,,
422,325965,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,1,A1BG,https://ctdbase.org/detail.go?type=gene&acc=1,,,1.0,A1BG,10116.0,Rattus norvegicus (Norway rat),Fenofibrate results in decreased expression of A1BG protein,,,PMID:20118634,https://www.ncbi.nlm.nih.gov/pubmed/20118634,20118634,,
423,325966,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,13,AADAC,https://ctdbase.org/detail.go?type=gene&acc=13,,,13.0,AADAC,9606.0,Homo sapiens (human),Fenofibrate results in increased expression of AADAC mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
424,326155,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116.0,Rattus norvegicus (Norway rat),Fenofibrate results in increased expression of ABCC2 mRNA,,,PMID:27765674,https://www.ncbi.nlm.nih.gov/pubmed/27765674,27765674,,
425,326156,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,8714,ABCC3,https://ctdbase.org/detail.go?type=gene&acc=8714,,,8714.0,ABCC3,10116.0,Rattus norvegicus (Norway rat),Fenofibrate results in decreased expression of ABCC3 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
426,326157,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,10116.0,Rattus norvegicus (Norway rat),Fenofibrate results in increased expression of ABCC4 mRNA,,,PMID:27765674,https://www.ncbi.nlm.nih.gov/pubmed/27765674,27765674,,
427,327452,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,53616,ADAM22,https://ctdbase.org/detail.go?type=gene&acc=53616,,,53616.0,ADAM22,10116.0,Rattus norvegicus (Norway rat),Fenofibrate results in increased expression of ADAM22 mRNA,,,PMID:32741897,https://www.ncbi.nlm.nih.gov/pubmed/32741897,32741897,,
428,327453,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,107,ADCY1,https://ctdbase.org/detail.go?type=gene&acc=107,,,107.0,ADCY1,9606.0,Homo sapiens (human),Fenofibrate results in decreased expression of ADCY1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
429,327454,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,126,ADH1C,https://ctdbase.org/detail.go?type=gene&acc=126,,,126.0,ADH1C,9606.0,Homo sapiens (human),Fenofibrate results in decreased expression of ADH1C mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
430,327455,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,127,ADH4,https://ctdbase.org/detail.go?type=gene&acc=127,,,127.0,ADH4,9606.0,Homo sapiens (human),Fenofibrate results in decreased expression of ADH4 mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
431,327458,3339,Drug Gene Interaction database (DGIdb),Fenofibrate,,FENOFIBRATE,https://www.dgidb.org/drugs/rxcui:8703,,CD40LG,https://www.dgidb.org/genes/hgnc:11935,,,959.0,CD40LG,9606.0,Homo sapiens (human),,,,,,,,
432,327459,3339,Drug Gene Interaction database (DGIdb),Fenofibrate,,FENOFIBRATE,https://www.dgidb.org/drugs/rxcui:8703,,ADIPOQ,https://www.dgidb.org/genes/hgnc:13633,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),,,,,,,,
433,327460,3339,Drug Gene Interaction database (DGIdb),Fenofibrate,,FENOFIBRATE,https://www.dgidb.org/drugs/rxcui:8703,,APOB,https://www.dgidb.org/genes/hgnc:603,,,338.0,APOB,9606.0,Homo sapiens (human),,,,,,,,
434,327461,3339,Drug Gene Interaction database (DGIdb),Fenofibrate,,FENOFIBRATE,https://www.dgidb.org/drugs/rxcui:8703,,APOB,https://www.dgidb.org/genes/hgnc:603,,,338.0,APOB,9606.0,Homo sapiens (human),,,,,,,,
435,329489,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116.0,Rattus norvegicus (Norway rat),Fenofibrate results in increased expression of CCND1 mRNA,,,PMID:17264098,https://www.ncbi.nlm.nih.gov/pubmed/17264098,17264098,,
436,329490,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,899,CCNF,https://ctdbase.org/detail.go?type=gene&acc=899,,,899.0,CCNF,10116.0,Rattus norvegicus (Norway rat),Fenofibrate results in increased expression of CCNF mRNA,,,PMID:32741897,https://www.ncbi.nlm.nih.gov/pubmed/32741897,32741897,,
437,329491,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,901,CCNG2,https://ctdbase.org/detail.go?type=gene&acc=901,,,901.0,CCNG2,9606.0,Homo sapiens (human),Fenofibrate results in decreased expression of CCNG2 mrna|fenofibrate results in increased expression of CCNG2 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
438,329492,3339,Comparative Toxicogenomics Database (CTD),Fenofibrate,D011345,Fenofibrate,https://ctdbase.org/detail.go?type=chem&acc=D011345,904,CCNT1,https://ctdbase.org/detail.go?type=gene&acc=904,,,904.0,CCNT1,10116.0,Rattus norvegicus (Norway rat),Fenofibrate affects the reaction [[streptozocin co-treated with dietary carbohydrates co-treated with dietary fats] affects the expression of CCNT1 protein]|fenofibrate affects the reaction [[streptozocin co-treated with dietary carbohydrates co-treated with dietary fats] affects the expression of CCNT1 mrna],,,PMID:20828602,https://www.ncbi.nlm.nih.gov/pubmed/20828602,20828602,,
439,328679,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,23708,GSPT2,https://ctdbase.org/detail.go?type=gene&acc=23708,,,23708.0,GSPT2,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of GSPT2 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
440,328680,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Fenvalerate metabolite results in decreased activity of GSR protein|fenvalerate results in decreased activity of GSR protein,,,PMID:15892188,https://www.ncbi.nlm.nih.gov/pubmed/15892188,15892188,,
441,328681,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,324366,GSTM.1,https://ctdbase.org/detail.go?type=gene&acc=324366,,,324366.0,gstm.1,7955.0,Danio rerio (zebrafish),Fenvalerate results in decreased expression of GSTM.1 mRNA,,,PMID:30553213,https://www.ncbi.nlm.nih.gov/pubmed/30553213,30553213,,
442,328682,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,9446,GSTO1,https://ctdbase.org/detail.go?type=gene&acc=9446,,,9446.0,GSTO1,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in decreased expression of GSTO1 protein,,,PMID:33656234,https://www.ncbi.nlm.nih.gov/pubmed/33656234,33656234,,
443,328683,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in decreased expression of GSTP1 protein,,,PMID:33656234,https://www.ncbi.nlm.nih.gov/pubmed/33656234,33656234,,
444,328684,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,103140,GSTT3,https://ctdbase.org/detail.go?type=gene&acc=103140,,,103140.0,Gstt3,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in decreased expression of GSTT3 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
445,328685,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,2969,GTF2I,https://ctdbase.org/detail.go?type=gene&acc=2969,,,2969.0,GTF2I,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of GTF2I protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
446,328686,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,149699,GTSF1L,https://ctdbase.org/detail.go?type=gene&acc=149699,,,149699.0,GTSF1L,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of GTSF1L mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
447,321203,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,79751,SLC25A22,https://ctdbase.org/detail.go?type=gene&acc=79751,,,79751.0,SLC25A22,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SLC25A22 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
448,321204,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,84275,SLC25A33,https://ctdbase.org/detail.go?type=gene&acc=84275,,,84275.0,SLC25A33,10090.0,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of SLC25A33 mRNA,,,PMID:24848799,https://www.ncbi.nlm.nih.gov/pubmed/24848799,24848799,,
449,322049,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6518,SLC2A5,https://ctdbase.org/detail.go?type=gene&acc=6518,,,6518.0,SLC2A5,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SLC2A5 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
450,322050,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,10568,SLC34A2,https://ctdbase.org/detail.go?type=gene&acc=10568,,,10568.0,SLC34A2,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SLC34A2 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
451,322051,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,7355,SLC35A2,https://ctdbase.org/detail.go?type=gene&acc=7355,,,7355.0,SLC35A2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SLC35A2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
452,322052,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,55343,SLC35C1,https://ctdbase.org/detail.go?type=gene&acc=55343,,,55343.0,SLC35C1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SLC35C1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SLC35C1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
453,322053,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,79939,SLC35E1,https://ctdbase.org/detail.go?type=gene&acc=79939,,,79939.0,SLC35E1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC35E1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of SLC35E1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
454,322054,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,728661,SLC35E2B,https://ctdbase.org/detail.go?type=gene&acc=728661,,,728661.0,SLC35E2B,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of SLC35E2B mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
455,322055,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,339665,SLC35E4,https://ctdbase.org/detail.go?type=gene&acc=339665,,,339665.0,SLC35E4,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC35E4 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of SLC35E4 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of SLC35E4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
456,322523,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG mrna|rosiglitazone promotes the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG mrna],,,PMID:19186324,https://www.ncbi.nlm.nih.gov/pubmed/19186324,19186324,,
457,322524,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),[dichlorodiphenyl dichloroethylene co-treated with [1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA,,,PMID:26200599,https://www.ncbi.nlm.nih.gov/pubmed/26200599,26200599,,
458,322525,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Diethylhexyl phthalate promotes the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mrna]|octocrylene promotes the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mrna]|oxybenzone promotes the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mrna],,,PMID:34864131,https://www.ncbi.nlm.nih.gov/pubmed/34864131,34864131,,
459,322526,3758,Drug Gene Interaction database (DGIdb),3-Isobutyl-1-methylxanthine,,3-ISOBUTYL-1-METHYL-7H-XANTHINE,https://www.dgidb.org/drugs/drugbank:DB07954,,PDE7A,https://www.dgidb.org/genes/hgnc:8791,,,5150.0,PDE7A,9606.0,Homo sapiens (human),,,,,,,,
460,323657,3806,Comparative Toxicogenomics Database (CTD),Juglone,C005134,juglone,https://ctdbase.org/detail.go?type=chem&acc=C005134,183000,GSTO-1,https://ctdbase.org/detail.go?type=gene&acc=183000,,,183000.0,gsto-1,6239.0,Caenorhabditis elegans,GSTO-1 protein results in decreased susceptibility to juglone,,,PMID:17901115,https://www.ncbi.nlm.nih.gov/pubmed/17901115,17901115,,
461,323658,3806,Comparative Toxicogenomics Database (CTD),Juglone,C005134,juglone,https://ctdbase.org/detail.go?type=chem&acc=C005134,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,9606.0,Homo sapiens (human),Juglone results in decreased expression of HES1 protein|[indomethacin co-treated with juglone] results in decreased expression of HES1 mrna|[indomethacin co-treated with juglone] results in decreased expression of HES1 protein|juglone results in decreased expression of HES1 mRNA,,,PMID:31916655,https://www.ncbi.nlm.nih.gov/pubmed/31916655,31916655,,
462,323659,3806,Comparative Toxicogenomics Database (CTD),Juglone,C005134,juglone,https://ctdbase.org/detail.go?type=chem&acc=C005134,178659,HSP-16.2,https://ctdbase.org/detail.go?type=gene&acc=178659,,,178659.0,hsp-16.2,6239.0,Caenorhabditis elegans,Juglone results in increased expression of HSP-16.2 protein|arctiin inhibits the reaction [juglone results in increased expression of HSP-16.2 protein]|matairesinol inhibits the reaction [juglone results in increased expression of HSP-16.2 protein]|arctigenin inhibits the reaction [juglone results in increased expression of HSP-16.2 protein],,,PMID:26141518,https://www.ncbi.nlm.nih.gov/pubmed/26141518,26141518,,
463,324141,3806,Comparative Toxicogenomics Database (CTD),Juglone,C005134,juglone,https://ctdbase.org/detail.go?type=chem&acc=C005134,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased phosphorylation of TP53 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
464,324142,3806,Comparative Toxicogenomics Database (CTD),Juglone,C005134,juglone,https://ctdbase.org/detail.go?type=chem&acc=C005134,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,9606.0,Homo sapiens (human),TXNRD1 protein results in increased reduction of juglone,,,PMID:21172426,https://www.ncbi.nlm.nih.gov/pubmed/21172426,21172426,,
465,324143,3806,Comparative Toxicogenomics Database (CTD),Juglone,C005134,juglone,https://ctdbase.org/detail.go?type=chem&acc=C005134,10587,TXNRD2,https://ctdbase.org/detail.go?type=gene&acc=10587,,,10587.0,TXNRD2,9606.0,Homo sapiens (human),TXNRD2 protein results in increased reduction of juglone,,,PMID:21172426,https://www.ncbi.nlm.nih.gov/pubmed/21172426,21172426,,
466,324144,3806,Comparative Toxicogenomics Database (CTD),Juglone,C005134,juglone,https://ctdbase.org/detail.go?type=chem&acc=C005134,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of VEGFA mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
467,324145,3820,IUPHAR/BPS Guide to PHARMACOLOGY,Kenpaullone,6000,kenpaullone,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6000,2030,glycogen synthase kinase 3 beta,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2030,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),Inhibition,pIC50,7.64,PMID:11013232,https://www.ncbi.nlm.nih.gov/pubmed/11013232,11013232,,
468,324146,3822,IUPHAR/BPS Guide to PHARMACOLOGY,Ketanserin,88,ketanserin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,214,D1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=214,P21728,D(1A) dopamine receptor,1812.0,DRD1,9606.0,Homo sapiens (human),Antagonist,pKi,6.7,PMID:1826762,https://www.ncbi.nlm.nih.gov/pubmed/1826762,1826762,,
469,324147,3825,Drug Gene Interaction database (DGIdb),Ketoprofen,,KETOPROFEN,https://www.dgidb.org/drugs/rxcui:6142,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606.0,Homo sapiens (human),,,,,,,,
470,324148,3825,Drug Gene Interaction database (DGIdb),Ketoprofen,,KETOPROFEN,https://www.dgidb.org/drugs/rxcui:6142,,PTGS1,https://www.dgidb.org/genes/hgnc:9604,,,5742.0,PTGS1,9606.0,Homo sapiens (human),,,,,,,,
471,324149,3825,BindingDB,Ketoprofen,50022271,2-(3-Benzoylphenyl)propionic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022271,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),1.850e+6,PMID:21534860|DOI:10.3109/14756366.2011.574130,https://www.ncbi.nlm.nih.gov/pubmed/21534860|https://doi.org/10.3109/14756366.2011.574130,21534860,10.3109/14756366.2011.574130,
472,323153,4055,Comparative Toxicogenomics Database (CTD),Menadione,D024483,Vitamin K 3,https://ctdbase.org/detail.go?type=chem&acc=D024483,463,ZFHX3,https://ctdbase.org/detail.go?type=gene&acc=463,,,463.0,ZFHX3,9606.0,Homo sapiens (human),Vitamin K 3 affects the expression of ZFHX3 mRNA,,,PMID:20044591,https://www.ncbi.nlm.nih.gov/pubmed/20044591,20044591,,
473,323154,4055,Comparative Toxicogenomics Database (CTD),Menadione,D024483,Vitamin K 3,https://ctdbase.org/detail.go?type=chem&acc=D024483,677,ZFP36L1,https://ctdbase.org/detail.go?type=gene&acc=677,,,677.0,ZFP36L1,9606.0,Homo sapiens (human),Vitamin K 3 affects the expression of ZFP36L1 mRNA,,,PMID:20044591,https://www.ncbi.nlm.nih.gov/pubmed/20044591,20044591,,
474,323155,4055,Comparative Toxicogenomics Database (CTD),Menadione,D024483,Vitamin K 3,https://ctdbase.org/detail.go?type=chem&acc=D024483,678,ZFP36L2,https://ctdbase.org/detail.go?type=gene&acc=678,,,678.0,ZFP36L2,9606.0,Homo sapiens (human),Vitamin K 3 affects the expression of ZFP36L2 mRNA,,,PMID:20044591,https://www.ncbi.nlm.nih.gov/pubmed/20044591,20044591,,
475,325478,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10116.0,Rattus norvegicus (Norway rat),Mesalamine inhibits the reaction [trinitrobenzenesulfonic acid results in decreased expression of IL10 protein],,,PMID:33412153,https://www.ncbi.nlm.nih.gov/pubmed/33412153,33412153,,
476,325479,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593.0,IL12B,10090.0,Mus musculus (house mouse),Mesalamine inhibits the reaction [dextran sulfate results in increased expression of IL12B mrna],,,PMID:33130971,https://www.ncbi.nlm.nih.gov/pubmed/33130971,33130971,,
477,325480,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,3605,IL17A,https://ctdbase.org/detail.go?type=gene&acc=3605,,,3605.0,IL17A,10090.0,Mus musculus (house mouse),Mesalamine inhibits the reaction [dextran sulfate results in increased expression of IL17A mrna],,,PMID:33130971,https://www.ncbi.nlm.nih.gov/pubmed/33130971,33130971,,
478,325481,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,10090.0,Mus musculus (house mouse),Mesalamine inhibits the reaction [dextran sulfate results in increased secretion of IL18 protein],,,PMID:37001609,https://www.ncbi.nlm.nih.gov/pubmed/37001609,37001609,,
479,325482,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,114548,NLRP3,https://ctdbase.org/detail.go?type=gene&acc=114548,,,114548.0,NLRP3,10090.0,Mus musculus (house mouse),Mesalamine inhibits the reaction [dextran sulfate results in increased expression of NLRP3 protein],,,PMID:37001609,https://www.ncbi.nlm.nih.gov/pubmed/37001609,37001609,,
480,325483,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Mesalamine inhibits the reaction [dextran sulfate results in increased activity of NOS2 protein],,,PMID:33130971,https://www.ncbi.nlm.nih.gov/pubmed/33130971,33130971,,
481,325484,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Mesalamine inhibits the reaction [dextran sulfate results in increased expression of NOS2 protein],,,PMID:36543318,https://www.ncbi.nlm.nih.gov/pubmed/36543318,36543318,,
482,325485,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),Mesalamine inhibits the reaction [acetic acid results in increased expression of NOS2 mrna],,,PMID:29518435,https://www.ncbi.nlm.nih.gov/pubmed/29518435,29518435,,
483,325486,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),Mesalamine promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mrna]|mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of PPARG protein]|[il1a protein co-treated with TNF protein co-treated with IFNG protein co-treated with mesalamine] results in increased activity of NFE2L2 protein|[il1a protein co-treated with TNF protein co-treated with IFNG protein co-treated with mesalamine] results in increased expression of GCLC mrna|mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with resveratrol] results in increased expression of HMOX1 mrna]|[il1a protein co-treated with TNF protein co-treated with IFNG protein co-treated with mesalamine] results in increased expression of PPARG protein,,,PMID:27818126,https://www.ncbi.nlm.nih.gov/pubmed/27818126,27818126,,
484,326614,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Pravastatin inhibits the reaction [SLCO1B1 protein results in increased uptake of mesalamine]|slco1b1 protein results in increased uptake of mesalamine|cyclosporine inhibits the reaction [SLCO1B1 protein results in increased uptake of mesalamine]|rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of mesalamine]|budesonide inhibits the reaction [SLCO1B1 protein results in increased uptake of mesalamine],,,PMID:21430235,https://www.ncbi.nlm.nih.gov/pubmed/21430235,21430235,,
485,326615,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,28234,SLCO1B3,https://ctdbase.org/detail.go?type=gene&acc=28234,,,28234.0,SLCO1B3,9606.0,Homo sapiens (human),Pravastatin inhibits the reaction [SLCO1B3 protein results in increased uptake of mesalamine]|slco1b3 protein results in increased uptake of mesalamine|rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of mesalamine]|budesonide inhibits the reaction [SLCO1B3 protein results in increased uptake of mesalamine]|cyclosporine inhibits the reaction [SLCO1B3 protein results in increased uptake of mesalamine],,,PMID:21430235,https://www.ncbi.nlm.nih.gov/pubmed/21430235,21430235,,
486,326616,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,9606.0,Homo sapiens (human),Rifampin inhibits the reaction [SLCO2B1 protein results in increased uptake of mesalamine]|slco2b1 protein results in increased uptake of mesalamine|pravastatin inhibits the reaction [SLCO2B1 protein results in increased uptake of mesalamine]|cyclosporine inhibits the reaction [SLCO2B1 protein results in increased uptake of mesalamine]|budesonide inhibits the reaction [SLCO2B1 protein results in increased uptake of mesalamine],,,PMID:21430235,https://www.ncbi.nlm.nih.gov/pubmed/21430235,21430235,,
487,326617,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,9021,SOCS3,https://ctdbase.org/detail.go?type=gene&acc=9021,,,9021.0,SOCS3,10116.0,Rattus norvegicus (Norway rat),Mesalamine inhibits the reaction [acetic acid results in increased expression of SOCS3 mrna],,,PMID:35122774,https://www.ncbi.nlm.nih.gov/pubmed/35122774,35122774,,
488,326618,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10116.0,Rattus norvegicus (Norway rat),Mesalamine inhibits the reaction [thioacetamide results in increased expression of SPP1 protein],,,PMID:29738702,https://www.ncbi.nlm.nih.gov/pubmed/29738702,29738702,,
489,326619,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10116.0,Rattus norvegicus (Norway rat),Mesalamine inhibits the reaction [trinitrobenzenesulfonic acid results in increased expression of SQSTM1 protein],,,PMID:33412153,https://www.ncbi.nlm.nih.gov/pubmed/33412153,33412153,,
490,326620,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090.0,Mus musculus (house mouse),Mesalamine inhibits the reaction [dextran sulfate results in increased phosphorylation of STAT3 protein],,,PMID:36543318,https://www.ncbi.nlm.nih.gov/pubmed/36543318,36543318,,
491,326621,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10116.0,Rattus norvegicus (Norway rat),Mesalamine inhibits the reaction [acetic acid results in increased phosphorylation of STAT3 protein],,,PMID:35122774,https://www.ncbi.nlm.nih.gov/pubmed/35122774,35122774,,
492,326622,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116.0,Rattus norvegicus (Norway rat),Mesalamine inhibits the reaction [thioacetamide results in increased expression of TGFB1 protein],,,PMID:29738702,https://www.ncbi.nlm.nih.gov/pubmed/29738702,29738702,,
493,321885,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,284424,MIR7-3HG,https://ctdbase.org/detail.go?type=gene&acc=284424,,,284424.0,MIR7-3HG,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of MIR7-3HG polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
494,321886,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,100126313,MIR744,https://ctdbase.org/detail.go?type=gene&acc=100126313,,,100126313.0,MIR744,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of MIR744 mRNA alternative form,,,PMID:22363424,https://www.ncbi.nlm.nih.gov/pubmed/22363424,22363424,,
495,321887,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,100126314,MIR877,https://ctdbase.org/detail.go?type=gene&acc=100126314,,,100126314.0,MIR877,10116.0,Rattus norvegicus (Norway rat),Methapyrilene affects the expression of MIR877 mRNA,,,PMID:24863736,https://www.ncbi.nlm.nih.gov/pubmed/24863736,24863736,,
496,321888,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,100124492,MIR879,https://ctdbase.org/detail.go?type=gene&acc=100124492,,,100124492.0,Mir879,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in increased expression of MIR879 mRNA alternative form,,,PMID:22363424,https://www.ncbi.nlm.nih.gov/pubmed/22363424,22363424,,
497,324641,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,101060226,NBPF19,https://ctdbase.org/detail.go?type=gene&acc=101060226,,,101060226.0,NBPF19,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of NBPF19 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
498,325313,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,4718,NDUFC2,https://ctdbase.org/detail.go?type=gene&acc=4718,,,4718.0,NDUFC2,9606.0,Homo sapiens (human),Methapyrilene results in decreased methylation of NDUFC2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
499,325314,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,4719,NDUFS1,https://ctdbase.org/detail.go?type=gene&acc=4719,,,4719.0,NDUFS1,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of NDUFS1 mrna|methapyrilene results in decreased expression of NDUFS1 protein,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
500,325315,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,4723,NDUFV1,https://ctdbase.org/detail.go?type=gene&acc=4723,,,4723.0,NDUFV1,9606.0,Homo sapiens (human),Methapyrilene results in decreased methylation of NDUFV1 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
501,325316,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,283131,NEAT1,https://ctdbase.org/detail.go?type=gene&acc=283131,,,283131.0,NEAT1,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of NEAT1 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
502,325317,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,4734,NEDD4,https://ctdbase.org/detail.go?type=gene&acc=4734,,,4734.0,NEDD4,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of NEDD4 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
503,325318,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,23327,NEDD4L,https://ctdbase.org/detail.go?type=gene&acc=23327,,,23327.0,NEDD4L,9606.0,Homo sapiens (human),Methapyrilene results in decreased methylation of NEDD4L intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
504,325319,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,4739,NEDD9,https://ctdbase.org/detail.go?type=gene&acc=4739,,,4739.0,NEDD9,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of NEDD9 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
505,325320,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,257194,NEGR1,https://ctdbase.org/detail.go?type=gene&acc=257194,,,257194.0,NEGR1,9606.0,Homo sapiens (human),Methapyrilene results in decreased methylation of NEGR1 intron|methapyrilene results in increased methylation of NEGR1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
506,325321,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,341676,NEK5,https://ctdbase.org/detail.go?type=gene&acc=341676,,,341676.0,NEK5,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of NEK5 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
507,328204,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,60506,NYX,https://ctdbase.org/detail.go?type=gene&acc=60506,,,60506.0,NYX,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of NYX polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
508,328205,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,259247,OBP3,https://ctdbase.org/detail.go?type=gene&acc=259247,,,259247.0,Obp3,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of OBP3 mRNA,,,PMID:15120968|PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15120968|https://www.ncbi.nlm.nih.gov/pubmed/15890375,15120968|15890375,,
509,328687,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,4983,OPHN1,https://ctdbase.org/detail.go?type=gene&acc=4983,,,4983.0,OPHN1,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of OPHN1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
510,326158,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),Miconazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of phenytoin]|miconazole inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of phenytoin] which results in increased abundance of hydroxyphenytoin],,,PMID:33961833,https://www.ncbi.nlm.nih.gov/pubmed/33961833,33961833,,
511,326159,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),Miconazole results in decreased activity of CYP2C9 protein,,,PMID:15328084,https://www.ncbi.nlm.nih.gov/pubmed/15328084,15328084,,
512,326160,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642.0,Cyp3a23-3a1,10116.0,Rattus norvegicus (Norway rat),Miconazole results in increased expression of CYP3A23-3A1 mRNA,,,PMID:12971794,https://www.ncbi.nlm.nih.gov/pubmed/12971794,12971794,,
513,326161,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Miconazole inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin],,,PMID:19299527,https://www.ncbi.nlm.nih.gov/pubmed/19299527,19299527,,
514,326162,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Miconazole results in increased expression of CYP3A4 mrna|miconazole promotes the reaction [NR1I2 results in increased expression of CYP3A4 mrna],,,PMID:17998298,https://www.ncbi.nlm.nih.gov/pubmed/17998298,17998298,,
515,326163,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Miconazole results in decreased activity of CYP3A4 protein,,,PMID:15135088|PMID:15969931,https://www.ncbi.nlm.nih.gov/pubmed/15135088|https://www.ncbi.nlm.nih.gov/pubmed/15969931,15135088|15969931,,
516,329830,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10090.0,Mus musculus (house mouse),Miconazole results in increased expression of PCNA mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
517,329831,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,78991,PCYOX1L,https://ctdbase.org/detail.go?type=gene&acc=78991,,,78991.0,PCYOX1L,10090.0,Mus musculus (house mouse),Miconazole results in increased expression of PCYOX1L mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
518,329832,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,10130,PDIA6,https://ctdbase.org/detail.go?type=gene&acc=10130,,,10130.0,PDIA6,10116.0,Rattus norvegicus (Norway rat),Miconazole results in decreased expression of PDIA6 mRNA,,,PMID:22262564,https://www.ncbi.nlm.nih.gov/pubmed/22262564,22262564,,
519,329833,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,18611,PEA15A,https://ctdbase.org/detail.go?type=gene&acc=18611,,,18611.0,Pea15a,10090.0,Mus musculus (house mouse),Miconazole results in increased expression of PEA15A mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
520,329980,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,54478,PIMREG,https://ctdbase.org/detail.go?type=gene&acc=54478,,,54478.0,PIMREG,10090.0,Mus musculus (house mouse),Miconazole results in increased expression of PIMREG mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
521,329981,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,5315,PKM,https://ctdbase.org/detail.go?type=gene&acc=5315,,,5315.0,PKM,10090.0,Mus musculus (house mouse),Miconazole results in increased expression of PKM mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
522,329982,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,5586,PKN2,https://ctdbase.org/detail.go?type=gene&acc=5586,,,5586.0,PKN2,10090.0,Mus musculus (house mouse),Miconazole results in decreased expression of PKN2 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
523,329983,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,8985,PLOD3,https://ctdbase.org/detail.go?type=gene&acc=8985,,,8985.0,PLOD3,10090.0,Mus musculus (house mouse),Miconazole results in increased expression of PLOD3 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
524,329984,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,5424,POLD1,https://ctdbase.org/detail.go?type=gene&acc=5424,,,5424.0,POLD1,10116.0,Rattus norvegicus (Norway rat),Miconazole results in increased expression of POLD1 mRNA,,,PMID:22262564,https://www.ncbi.nlm.nih.gov/pubmed/22262564,22262564,,
525,329985,4189,Comparative Toxicogenomics Database (CTD),Miconazole,D008825,Miconazole,https://ctdbase.org/detail.go?type=chem&acc=D008825,5425,POLD2,https://ctdbase.org/detail.go?type=gene&acc=5425,,,5425.0,POLD2,10090.0,Mus musculus (house mouse),Miconazole results in increased expression of POLD2 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
526,324964,5391,DrugBank,Temazepam,DB00231,Temazepam,https://www.drugbank.ca/drugs/DB00231,BE0008668,Gamma-aminobutyric acid receptor subunit alpha-3,https://www.drugbank.ca/bio_entities/BE0008668,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
527,324965,5391,DrugBank,Temazepam,DB00231,Temazepam,https://www.drugbank.ca/drugs/DB00231,BE0008668,Gamma-aminobutyric acid receptor subunit alpha-5,https://www.drugbank.ca/bio_entities/BE0008668,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558.0,GABRA5,9606.0,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
528,324966,5391,DrugBank,Temazepam,DB00231,Temazepam,https://www.drugbank.ca/drugs/DB00231,BE0008668,Gamma-aminobutyric acid receptor subunit gamma-1,https://www.drugbank.ca/bio_entities/BE0008668,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,2565.0,GABRG1,9606.0,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
529,326322,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),"[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased activity of CASP3 protein|zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CDH1 protein]|zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein]|[ifng protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CDH1 protein|[ifng protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein",,,PMID:16844947,https://www.ncbi.nlm.nih.gov/pubmed/16844947,16844947,,
530,326323,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [[calcitriol co-treated with lipopolysaccharide, escherichia coli O111 B4] results in increased secretion of TNF protein]",,,PMID:20089671,https://www.ncbi.nlm.nih.gov/pubmed/20089671,20089671,,
531,326324,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [FCER1A protein results in increased expression of TNF mrna]|n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [FCER1A protein results in increased expression of TNF protein]",,,PMID:16818790,https://www.ncbi.nlm.nih.gov/pubmed/16818790,16818790,,
532,326767,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,57181,SLC39A10,https://ctdbase.org/detail.go?type=gene&acc=57181,,,57181.0,SLC39A10,9606.0,Homo sapiens (human),"[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with zinc] results in decreased expression of SLC39A10 mrna|[zinc co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A10 mrna|[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A10 mRNA",,,PMID:19720134,https://www.ncbi.nlm.nih.gov/pubmed/19720134,19720134,,
533,326768,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,57181,SLC39A10,https://ctdbase.org/detail.go?type=gene&acc=57181,,,57181.0,SLC39A10,10090.0,Mus musculus (house mouse),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [MTF1 protein binds to SLC39A10 promoter]|n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 protein|dactinomycin inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mrna]|zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mrna]|n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mRNA",,,PMID:21738690,https://www.ncbi.nlm.nih.gov/pubmed/21738690,21738690,,
534,326769,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,91252,SLC39A13,https://ctdbase.org/detail.go?type=gene&acc=91252,,,91252.0,SLC39A13,10090.0,Mus musculus (house mouse),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLC39A13 mRNA",,,PMID:22228435,https://www.ncbi.nlm.nih.gov/pubmed/22228435,22228435,,
535,326770,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,23516,SLC39A14,https://ctdbase.org/detail.go?type=gene&acc=23516,,,23516.0,SLC39A14,9606.0,Homo sapiens (human),"[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A14 mRNA",,,PMID:19720134,https://www.ncbi.nlm.nih.gov/pubmed/19720134,19720134,,
536,326771,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,23516,SLC39A14,https://ctdbase.org/detail.go?type=gene&acc=23516,,,23516.0,SLC39A14,9940.0,Ovis aries (sheep),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A14 mrna|zinc chloride inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A14 mrna]",,,PMID:21239534,https://www.ncbi.nlm.nih.gov/pubmed/21239534,21239534,,
537,326772,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,29986,SLC39A2,https://ctdbase.org/detail.go?type=gene&acc=29986,,,29986.0,SLC39A2,9606.0,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLC39A2 mRNA",,,PMID:18385089,https://www.ncbi.nlm.nih.gov/pubmed/18385089,18385089,,
538,326773,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,29986,SLC39A2,https://ctdbase.org/detail.go?type=gene&acc=29986,,,29986.0,SLC39A2,9606.0,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A2 mRNA",,,PMID:12756304,https://www.ncbi.nlm.nih.gov/pubmed/12756304,12756304,,
539,326972,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,53919,SLCO1C1,https://ctdbase.org/detail.go?type=gene&acc=53919,,,53919.0,SLCO1C1,9606.0,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLCO1C1 mRNA",,,PMID:17622302|PMID:19013360,https://www.ncbi.nlm.nih.gov/pubmed/17622302|https://www.ncbi.nlm.nih.gov/pubmed/19013360,17622302|19013360,,
540,326973,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,79086,SMIM7,https://ctdbase.org/detail.go?type=gene&acc=79086,,,79086.0,SMIM7,9606.0,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SMIM7 mRNA",,,PMID:12756304,https://www.ncbi.nlm.nih.gov/pubmed/12756304,12756304,,
541,327301,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,6776,STAT5A,https://ctdbase.org/detail.go?type=gene&acc=6776,,,6776.0,STAT5A,10090.0,Mus musculus (house mouse),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [IL2 protein results in increased phosphorylation of STAT5A protein]",,,PMID:20201035,https://www.ncbi.nlm.nih.gov/pubmed/20201035,20201035,,
542,327302,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777.0,STAT5B,10090.0,Mus musculus (house mouse),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [IL2 protein results in increased phosphorylation of STAT5B protein]",,,PMID:20201035,https://www.ncbi.nlm.nih.gov/pubmed/20201035,20201035,,
543,327303,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,79689,STEAP4,https://ctdbase.org/detail.go?type=gene&acc=79689,,,79689.0,STEAP4,9606.0,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of STEAP4 mRNA",,,PMID:12756304,https://www.ncbi.nlm.nih.gov/pubmed/12756304,12756304,,
544,327304,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,6793,STK10,https://ctdbase.org/detail.go?type=gene&acc=6793,,,6793.0,STK10,9606.0,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of STK10 mRNA",,,PMID:12756304,https://www.ncbi.nlm.nih.gov/pubmed/12756304,12756304,,
545,327305,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,11276,SYNRG,https://ctdbase.org/detail.go?type=gene&acc=11276,,,11276.0,SYNRG,9606.0,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SYNRG mRNA",,,PMID:12756304,https://www.ncbi.nlm.nih.gov/pubmed/12756304,12756304,,
546,519359,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,83716,CRISPLD2,https://ctdbase.org/detail.go?type=gene&acc=83716,,,83716.0,CRISPLD2,9606.0,Homo sapiens (human),Urethane results in increased expression of CRISPLD2 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
547,542466,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,5686,PSMA5,https://ctdbase.org/detail.go?type=gene&acc=5686,,,5686.0,PSMA5,10116.0,Rattus norvegicus (Norway rat),Pirinixic acid results in increased expression of PSMA5 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
548,542467,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,5687,PSMA6,https://ctdbase.org/detail.go?type=gene&acc=5687,,,5687.0,PSMA6,10090.0,Mus musculus (house mouse),Pirinixic acid results in increased expression of PSMA6 mRNA,,,PMID:18301758|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/23811191,18301758|23811191,,
549,597125,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,10082,GPC6,https://ctdbase.org/detail.go?type=gene&acc=10082,,,10082.0,GPC6,10090.0,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of GPC6 mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
550,605779,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7305,TYROBP,https://ctdbase.org/detail.go?type=gene&acc=7305,,,7305.0,TYROBP,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in increased expression of TYROBP mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
551,576949,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,342357,ZKSCAN2,https://ctdbase.org/detail.go?type=gene&acc=342357,,,342357.0,ZKSCAN2,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of ZKSCAN2 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
552,576950,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,342357,ZKSCAN2,https://ctdbase.org/detail.go?type=gene&acc=342357,,,342357.0,ZKSCAN2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ZKSCAN2 mRNA,,,PMID:25181051|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|34947998,,
553,1143360,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,285596,FAM153A,https://ctdbase.org/detail.go?type=gene&acc=285596,,,285596.0,FAM153A,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of FAM153A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
554,1143361,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,285596,FAM153A,https://ctdbase.org/detail.go?type=gene&acc=285596,,,285596.0,FAM153A,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of FAM153A intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
555,1657163,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,94056,SYAP1,https://ctdbase.org/detail.go?type=gene&acc=94056,,,94056.0,SYAP1,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of SYAP1 mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
556,1617471,636402,Comparative Toxicogenomics Database (CTD),Carbenoxolone sodium,D002229,Carbenoxolone,https://ctdbase.org/detail.go?type=chem&acc=D002229,3291,HSD11B2,https://ctdbase.org/detail.go?type=gene&acc=3291,,,3291.0,HSD11B2,9606.0,Homo sapiens (human),Carbenoxolone results in decreased activity of HSD11B2 protein,,,PMID:15743993|PMID:21786805,https://www.ncbi.nlm.nih.gov/pubmed/15743993|https://www.ncbi.nlm.nih.gov/pubmed/21786805,15743993|21786805,,
557,1617128,637566,Comparative Toxicogenomics Database (CTD),Geraniol,C007836,geraniol,https://ctdbase.org/detail.go?type=chem&acc=C007836,8607,RUVBL1,https://ctdbase.org/detail.go?type=gene&acc=8607,,,8607.0,RUVBL1,9606.0,Homo sapiens (human),Geraniol results in decreased expression of RUVBL1 mRNA,,,PMID:27683099,https://www.ncbi.nlm.nih.gov/pubmed/27683099,27683099,,
558,1617129,637566,Comparative Toxicogenomics Database (CTD),Geraniol,C007836,geraniol,https://ctdbase.org/detail.go?type=chem&acc=C007836,10856,RUVBL2,https://ctdbase.org/detail.go?type=gene&acc=10856,,,10856.0,RUVBL2,9606.0,Homo sapiens (human),Geraniol results in decreased expression of RUVBL2 mRNA,,,PMID:27683099,https://www.ncbi.nlm.nih.gov/pubmed/27683099,27683099,,
559,1617130,637566,Comparative Toxicogenomics Database (CTD),Geraniol,C007836,geraniol,https://ctdbase.org/detail.go?type=chem&acc=C007836,6304,SATB1,https://ctdbase.org/detail.go?type=gene&acc=6304,,,6304.0,SATB1,9606.0,Homo sapiens (human),Geraniol results in increased expression of SATB1 mRNA,,,PMID:27683099,https://www.ncbi.nlm.nih.gov/pubmed/27683099,27683099,,
560,1617131,637566,Comparative Toxicogenomics Database (CTD),Geraniol,C007836,geraniol,https://ctdbase.org/detail.go?type=chem&acc=C007836,6317,SERPINB3,https://ctdbase.org/detail.go?type=gene&acc=6317,,,6317.0,SERPINB3,9606.0,Homo sapiens (human),Geraniol results in increased expression of SERPINB3 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
561,1617132,637566,Comparative Toxicogenomics Database (CTD),Geraniol,C007836,geraniol,https://ctdbase.org/detail.go?type=chem&acc=C007836,6493,SIM2,https://ctdbase.org/detail.go?type=gene&acc=6493,,,6493.0,SIM2,9606.0,Homo sapiens (human),Geraniol results in increased expression of SIM2 mRNA,,,PMID:27683099,https://www.ncbi.nlm.nih.gov/pubmed/27683099,27683099,,
562,1657164,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,8309,ACOX2,https://ctdbase.org/detail.go?type=gene&acc=8309,,,8309.0,ACOX2,10090.0,Mus musculus (house mouse),Quercetin results in increased expression of ACOX2 mRNA,,,PMID:16455785,https://www.ncbi.nlm.nih.gov/pubmed/16455785,16455785,,
